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Heme Peroxidase HPX-2 Protects Caenorhabditis elegans from Pathogens 
Yi Liu, M.S. 
Advisory Professor:  Danielle A. Garsin, Ph.D. 
Heme-containing peroxidases are important components of innate immunity. Many of 
them functionally associate with NADPH oxidase (NOX)/dual oxidase (DUOX) enzymes by 
using the hydrogen peroxide they generate in downstream reactions. In Caenorhabditis 
elegans, a ShkT-containing peroxidase, SKPO-1, and the dual oxidase, BLI-3, contribute to 
resistance against the human pathogen Enterococcus faecalis, likely functioning in conjunction 
with each other. However, the exact mechanism(s) by which peroxidases and NOX/DUOXs 
contribute to pathogen resistance remain unclear. Here, we demonstrated that another 
peroxidase, HPX-2 (Heme-PeroXidase 2), is required for resistance against some, but not all 
pathogens. Tissue specific RNA interference (RNAi) revealed that HPX-2 functionally localizes 
to the hypodermis of the worm. In congruence with this observation, hpx-2 mutant animals 
possessed a slightly weaker cuticle structure, indicated by higher permeability to a DNA dye, but 
exhibited no obvious morphological defects. In addition, fluorescent labeling of HPX-2 revealed 
its expression in the pharynx, an organ in which BLI-3 also resides. Interestingly, loss of HPX-2 
increased intestinal colonization of E. faecalis, suggesting its role in the pharynx may limit 
intestinal colonization. Moreover, disruption of a catalytic residue in the peroxidase domain of 
HPX-2 resulted in decreased survival on E. faecalis, indicating its peroxidase activity is required 
for pathogen resistance. Finally, RNA-seq analysis of an hpx-2 mutant revealed changes in 
genes encoding for cuticle structural components under the non-pathogenic conditions. Under 
pathogenic conditions, genes involved in infection response were differentially regulated to a 
greater degree, likely due to increased microbial burden. In conclusion, the characterization of 
 vi 
the heme-peroxidase, HPX-2, revealed that it contributes to C. elegans pathogen resistance 
through a role in generating cuticle material in the hypodermis and pharynx. 
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Chapter 1: Introduction 
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ROS in innate immunity 
Reactive Oxygen Species (ROS) production is one of the first responses from host cells 
when infection occurs. After successful pathogen recognition, superoxide (O2-) and/or its 
dismutase product hydrogen peroxide (H2O2) are generated for two major purposes: 1) to serve 
as signal molecules and activate downstream immune factors and 2) to generate the oxidative 
burst and directly eliminate pathogens. 
ROS as immune signals 
The function of ROS as an indirect signal for activation of the immune response has 
been demonstrated in multiple organisms. In plants, ROS were shown to be involved in the 
hyper-sensitive response (HR) - a form of programmed cell death (PCD) in multiple species 
including Arabidopsis thaliana, Glycine max (soybean), and Nicotiana tobacum (tobacco) (1-4). 
Upon activation of the HR, ROS are produced by the plant NADPH oxidase respiratory burst 
oxidase homologue (RBOH) and glycolate oxidase (GOX) (1-4). ROBH generates O2- that can 
be converted into H2O2 by superoxide dismutase, whereas GOX directly produces H2O2 from 
the glyoxylate reaction. Once the level of H2O2 reaches the 6 mM threshold in the infected cells, 
HR-mediated PCD is triggered in a calcium-mediated fashion, resulting in the death of the 
infected cells and preventing the spread of the pathogen (3-5).  In other instances, ROS 
associate with salicylic acid (SA), a plant signaling molecule involved in the defense response, 
to trigger the systematic acquired resistance (SAR) (6).  
In Drosophila melanogaster, ROS play an important role as signal molecules for gut-to-
fat body innate immune communication (7). Specifically, intestinal infection by enterobacteria 
Erwinia carotovora carotovora 15 (Ecc15) in Drosophila larva results in localized ROS 
production in the intestine, which then induces nitric oxide (NO) production. The elevated NO 
level in the intestine triggers a global immune response in the fat body, a major immune organ 
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in insects, resulting in the production of an anti-microbial peptide (AMP) called diptericin. This 
process ensures the systematic control and confinement of the pathogen to the intestine (7, 8).  
In zebrafish, ROS, specifically H2O2, serve as signal molecules for recruiting leukocytes 
to the wounded sites (9). Using a genetically encoded H2O2 reporter, it was shown that an 
increasing concentration gradient of H2O2 from the injured fish tail fin to the nearby areas leads 
to the rapid recruitment of leukocytes to the injured site (9). This process requires a dual 
oxidase (DUOX) and DUOX inhibition disrupts the gradient, abolishing leukocyte recruitment 
(9).  
In humans, the signaling function of ROS was first illustrated through the discovery that 
micromolar concentrations of H2O2 activate the NF-κB transcription factor in T cells (10). More 
recently, it has been demonstrated that H2O2 produced by DUOX2 is involved in NOD2-
dependent signal transduction resulting in protection against Listeria monocytogenes infection in 
epithelial cells (11).  
ROS as antimicrobial effectors   
Next, I will discuss how ROS serve as a direct antimicrobial reagent during infection with 
an emphasis on mammalian systems. While O2- and H2O2 are not considered strong 
microbicidal reagents, they can be converted into other oxidants that exhibit stronger 
antimicrobial activity. Peroxidases are the enzymes that carry out such reactions. A canonical 
example is the oxidative burst in macrophages and neutrophils, generated by formation of the 
potent bacterial cytotoxin hypochlorous acid (HOCl). Specifically, when bacteria are engulfed by 
neutrophils, H2O2 produced by an NADPH oxidase (NOX2, specifically, see next section) is 
subsequently converted into HOCl through a reaction with chloride ion catalyzed by 
myeloperoxidase (MPO) (reviewed in (12). HOCl generated in the phagolysome modifies 
tyrosine residues in the bacterial protein, forming 3-chlorotyrosine which serves as a marker for 
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bacterial killing (13, 14). Mutations in the NADPH oxidase or MPO results in decreased amounts 
of 3-chlorotyrosine bound bacterial protein and insufficient microbial clearance (12, 14).  
Another example of ROS serving as direct effectors for pathogen elimination is the 
generation of the potent antimicrobial anion hypothiocyanite (OSCN-) through the oxidation of 
thiocyanate (SCN-) by lactoperoxidase (LPO) using H2O2 produced by dual oxidase (DUOX) as 
a substrate (15-18).  During Pseudomonas aeruginosa infection of bronchial epithelial cells, the 
levels of H2O2 and subsequently OSCN- are increased, contributing to increased pathogen 
clearance (19). In addition to P. aeruginosa clearance, OSCN- is also involved in 
Staphylococcus aureus and Burkholderia cepacia clearance (19, 20). Disruption of the DUOX-
LPO-SCN- system would lead to a decrease in pathogen clearance efficiency. For example, 
inhibition of LPO activity leads to decreased pathogen clearance in sheep airways (15). 
Additionally, cystic fibrosis (CF) patients with mutated CF transmembrane conductance 
regulator (CFTR), which causes impaired transport of SCN- to the apical membrane and 
decreased production of OSCN-, cannot efficiently clear P. aeruginosa and S. aureus from their 
airways (19, 20).  
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NADPH Oxidases (NOXs), Dual Oxidases (DUOXs), and Peroxidases 
As mentioned before, ROS serve as both signal molecules and microbicidal effectors in 
response to infection. NADPH oxidase (NOX) and dual oxidase (DUOX) produce ROS in the 
form of superoxide (O2-) and H2O2 whereas peroxidases can utilize the H2O2 to carry out further 
reactions such as generating a more potent anti-microbial oxidant. 
 
NOX and DUOX 
Five NOX (NOX1-5) and two DUOX (DUOX1 and 2) enzymes have been identified in 
mammalian cells (21). NOXs are transmembrane proteins that harbor the NADPH domain and 
flavin adenine dinucleotide (FAD)-binding domain, six transmembrane domains, and four 
evolutionally conserved histidine residues for heme-binding and catalytic activity (21). 
Expressed at different tissue/cellular locations, NOX/DUOX family members produce either 
superoxide or hydrogen peroxide that function in a variety of cellular processes including protein 
modification, redox signaling, apoptosis, and host defense (Table 1.1) (21, 22) (23). NOX2, or 
phagocytic NOX, was the first member discovered in the NOX/DUOX family and was 
characterized as generating the oxidative burst in macrophages and neutrophils for host 
defense (24). Mutations in NOX2 cause Chronic Granulomatous Diseases (CGD) with 
significant increased susceptibility to a variety of pathogen infections (24).  
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NOX/DUOX 
 
Location Function 
NOX1 Colon 
 
Host defense 
NOX2 
(phagocytic 
NOX) 
Phagolysome of macrophage and 
neutrophil 
 
Oxidative burst for host defense 
NOX3 Inner ear 
 
Otoconia morphogenesis 
NOX4 Kidney, vascular cells, osteoclasts 
 
unclear 
NOX5 Lymphoid tissue and testis  
 
Signaling process 
DUOX1 Thyroid and respiratory epithelia 
 
Thyroid hormone synthesis and 
epithelia host defense 
 
DUOX2 Thyroid and gastrointestinal glandular 
epithelia 
 
Thyroid hormone synthesis and 
epithelia host defense 
Table 1.1 Localization and function of mammalian NOX/DUOX family. This table is a 
summary of a mini-review listed in the reference as (25).  
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DUOXs are structurally different from NOXs in that they possess an extracellular 
peroxidase-like domain at their N-terminus. Functionally, instead of producing O2-, DUOXs 
produce H2O2 through oxidation reactions. In addition to host defense function in mammals, 
DUOXs also play an important role in the stabilization of the extracellular matrix by crosslinking 
tyrosine in multiple organisms including Drosophila and Anopheles gambiae (26, 27).  
In C. elegans, the only functional NOX/DUOX is BLI-3 (also known as Ce-DUOX1) was 
characterized for its role in maintaining extracellular matrix integrity, protecting worms from 
infection, and regulating the oxidative response.  Similar to human DUOX1 and DUOX2, BLI-3 
possesses a highly conserved NADPH and FAD binding domain at its C-terminus and an 
extracellular peroxidase domain at the N-terminus (28). Functionally, both its NADPH oxidase 
and peroxidase activity are important for cuticle crosslinking (28, 29). Cuticle is the collagenous 
extra cellular matrix that serves as the exoskeleton of the worm, providing structure and 
protection from the environment (30). RNAi knockdown of BLI-3 or mutations in either domain 
result in severe cuticle blistering due to the insufficient di- and tri- tyrosine crosslinking of 
collagen proteins (29). A heme peroxidase, MLT-7, is also involved in the tyrosine cross-linking 
process, presumably by utilizing the H2O2 generated by the BLI-3 NOX domain as a co-
substrate (29).  In addition to cuticle crosslinking, BLI-3 is also involved in pathogen resistance 
and the response to oxidative stress through the p38 MAPK and insulin signaling pathways (see 
the last section in this chapter for more detail).  
Given the function of BLI-3 in cuticle cross-linking, innate immunity, and oxidative stress 
response, multiple internal and external signals can activate its expression and activity. The 
expression of BLI-3 peaks during the molting cycle, corresponding to cuticle biosynthesis. 
Additionally, environmental stress such as pathogen infection and oxidative stress stimulate its 
activity, resulting in an increased amount of ROS.  
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Peroxidases 
Heme peroxidases catalyze a variety of oxidative reactions by utilizing H2O2 as an 
electron acceptor and heme as redox cofactor.  The four families of peroxidases are 1) the 
catalase superfamily, aka bacterial, fungi, and plant peroxidase superfamily 2) the 
cyclooxygenase superfamily, aka animal peroxidase superfamily (although members of the this 
group include non-animal species)  3) the chlorite dismutase superfamily and (4) the 
peroxygenase superfamily (32). All the mammalian peroxidases belong to the cyclooxygenase 
super family (32). Some well-studied examples include eosinophil peroxidase (EPO), thyroid 
peroxidase (TPO), and previously mentioned MPO and LPO. Their differential expression, 
location and function are listed in Table 1.2.  
Peroxidases in the cyclooxygenase family shares two conserved sequence signatures: -
X-G-Q-X-X-D-H-D-X- and -X-R-X-X-E-X- (32).  The first sequence is characterized by the distal 
catalytic histidine and two aspartates that are involved in heme-binding. The second conserved 
sequence includes a highly conserved catalytic arginine residue followed by a glutamate that is 
involved in forming an ester bond with heme (32). In human MPO, the crucial catalytic residues 
are Gln257, His261, and Arg405, with the function of forming the binding pockets for H2O2 (33). 
The latter two residues (His 261 and Arg 405) are also shown to be conserved in plant and 
yeast peroxidases (34, 35). In C. elegans, the distal histidine and arginine are present in all the 
peroxidases identified including MLT-7, SKPO-1, and HPX-2. The only exception is the 
peroxidase domain of the DUOX BLI-3, where the distal histidine has been replaced by a 
tyrosine residue (Tyr106) (Figure 4.9), which is believed to cause its slower turnover rate 
compared to other mammalian peroxidases (36). Functionally, mammalian heme peroxidases 
are capable of oxidizing small aromatic substrates as well as iodide (I-), thiocyanate (SCN-), and 
bromide (Br-), giving rise to their various functions in protein modification and generation of 
antimicrobial substances (33). 
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Peroxidase 
 
Location Function 
MPO Neutrophils and macrophages 
 
Oxidative burst for host defense  
LPO Leukocytes in milk, tears, and saliva 
 
Bactericidal compound production 
EPO Eosinophils  
 
Bactericidal compound production 
TPO Thyroid gland  
 
Thyroid hormone production 
Table 1.2 Localization and function of some of the mammalian peroxidases. This table is a 
summary of a review listed in the reference as (33). 
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Mitochondrial ROS 
In addition to NOX/DUOX enzymes, mitochondria are also a major source of ROS 
(mtROS).  As a crucial cellular organelle, the most prominent function of mitochondrion is to 
generate ATP by a serious of oxidation reactions in the electron transport chain. mtROS are 
produced as a major by-product during the process.  Although traditionally mtROS are viewed 
as destructive molecules that cause a variety types of cell damage, they are also involved in 
various metabolic and innate immunity signaling pathways that are beneficial and homeostatic 
(37, 38). Similar to the NADPH derived ROS, mtROS can function as a direct source of 
antimicrobial oxidants or as a signal to regulate innate immune responses in mammals (39). In 
C. elegans, although mtROS have been shown to function in promoting hypodermal wound 
healing and longevity under stress conditions, their roles in innate immunity have not been 
characterized (40, 41). 
Complex I, the largest complex of the respiratory chain, is the major source of mtROS 
(39). During a bacterial infection, mtROS production is stimulated and mitochondria are directed 
towards newly formed phagosomes to join forces with NADPH-derived ROS for the bacteria 
eliminating oxidative burst (39). This process is regulated by multiple pathways starting from 
Pathogen Associated Molecular Pattern (PAMP) recognition by host cells. Upon successful 
recognition of pathogenic microbes, four distinct and partially overlapping signaling pathways 
are activated, resulting in: 1) NADPH oxidase activation and increased ROS production in the 
phagosome, 2) Proinflammatory cytokine production, 3) Release of the ubiquitin ligase TRAF6 
from Rac-GDP which promotes TRAF6-ECSIT compound formation, and 4) Serine-threonine 
kinases Mst1/2 activation. These four pathways all have positive roles in reducing the oxidative 
phosphorylation in Complex I and increasing mtROS formation (42-44). Additionally, the 
TRAF6-ECSIT and Mst1/Mst2 pathways contribute to the movement of ROS-enriched 
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mitochondria towards the phagosome through the activation of F-actin assembly by the 
production of Rac-GTP (45, 46).   
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C. elegans as an infection model 
C. elegans pathogens 
C. elegans is a classic model organism in which fundamental biological processes, such 
as development and aging, have been studied since the 1970s (47-49).  Only in the past two 
decades has it become a popular model for infectious diseases. Its simplified immune system 
and well-characterized biology make it ideal to study host-microbe interactions. As of today, a 
large number of pathogens, including fungi, bacteria, and even viruses of clinical relevance, 
have been demonstrated to effectively infect C. elegans (50). Generally speaking, there are two 
major modes by which microbes harm C. elegans: (1) secretion of toxins and (2) colonization 
and physical disruption of the worm body. These two mechanisms of causing disease in the 
worm apply to many pathogens, sometimes in a non-mutually exclusive way. In terms of the site 
of infection, the intestinal lumen and the hypodermis are the two major locations where infection 
starts. In this section, I will discuss some of the fungal and bacterial pathogens for which C. 
elegans is utilized as an infection model.  
One of the well characterized fungal pathogens is Candida albicans, an opportunistic 
pathogen that can also be found as a commensal of the human microbiome. C. albicans can 
colonize the intestine of the worms, causing distal intestinal distention (51). Unlike live C. 
albicans, heat-killed C. albicans were avirulent, suggesting the pathogenesis is not mediated by 
toxins  (51) . In contrast to C. albicans, another fungal pathogen, Cryptococcus neoformans, kills 
C. elegans independently of whether the microbe is alive, indicating that the mode of killing is 
through the production of toxin (52, 53) .  In addition to intestinal colonization, some fungal 
species infect the worms through the cuticle. One example is Drechmeria conisopora, a natural 
pathogen of C. elegans. It utilizes its conidia to adhere to the head and vulva of the worm, then 
invades the worm body by penetrating the cuticle around the head and through the natural 
orifice around the vulva (54).  
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Pseudomonas aeruginosa is probably the most studied bacterial pathogen in C. elegans 
and indeed was the first pathogen ever reported to infect! Depending on the culture media 
conditions, P. aeruginosa utilizes either toxin-mediated killing or colonization of the intestine to 
kill C. elegans (55, 56). “Fast-killing” occurs when P. aeruginosa is grown under nutrient rich 
and high osmolarity conditions in which the bacteria secrete various toxins to mediate killing of 
the worms in a matter of hours. On the other hand, “slow-killing” is when bacteria are grown on 
minimal media, colonize the intestine, and kill the worms over the course of a few days. Slow-
killing requires live bacteria whereas fast-killing does not. P. aeruginosa is not the only bacteria 
that secretes toxins/effectors that kill C. elegans.  Many other bacteria have similar mechanisms 
of killing, although the effectors they produce varies. Some of the other toxin producing bacteria 
include E. coli EHEC (Shiga toxin) (57), Baccillus thuringiensis (pore-forming crystal protein) 
(58), Staphylococcus aureus (α-hemolysin) (59), and many Streptococcus species including S. 
pyogenes (hydrogen peroxide) (60).  
Enterococcus faecalis is another important human pathogen that can be found in the gut 
flora of healthy individuals. This Gram-positive bacterium can cause a variety of diseases in 
immune compromised patients and is a leading cause of nosocomial infection. E. faecalis kills 
C. elegans by intestinal colonization and propagation with an LT50 of about 4 days (61). 
Transmission electron microscopy (TEM) revealed actively dividing bacteria in the intestine (72). 
E. faecalis also prevents C. elegans from propagating, although adults will lay eggs onto the 
bacteria lawn; none develop into adults. Consistent with other animal models, mutations in the 
major quorum sensing regulatory system, fsr, or in two extracellular protease encoding genes, 
gelE and/or sprE, attenuate killing (62, 63). In addition, production of cytolysin, a toxin that can 
lyse host cells, significantly increased the rate of killing (62, 64).  
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Kingdoms  Pathogens  Infection and 
Pathogenic Mode  
Host Pathway 
and Response  
References  
 
 
 
Bacteria 
P. aeruginosa  Feeding; slow killing by 
colonization; fast killing 
by toxin 
PMK-1, ZIP-2, 
FSHR-1 
dependent 
pathways  
(55) (65, 66) 
(67) 
S. enterica Feeding; killing by 
colonization; LPS as 
virulence factor  
PMK-1-
dependant 
programed cell 
death pathway 
(68) 
S. aureus  Feeding, α-hemolysin as 
virulence factor  
SEK-1 and 
NSY-1 
dependent p38 
MAP kinase 
pathway and 
TFEB mediated 
transcriptional 
response  
(59, 69) 
C. diphtheriae Feeding, diphtheriae toxin 
and pili as virulence 
factor  
Not analyzed  (70) 
E. faecalis  Feeding, killing by 
colonization  
p38 MAP kinase 
pathway 
(62, 71) 
E. coli (EHEC) Feeding, killing by 
colonization and toxins 
  
S. pyogenes  Feeding; colonization; 
hydrogen peroxide as 
virulence factor 
Not analyzed (60) 
Fungi C. albicans Feeding; colonization  PMK-1/p-38 
MAPK 
pathways  
(51) 
 
C. neoformans  
Feeding; colonization; 
laccase; polysaccharide 
capsule and/or 
melanization as virulence 
factors  
CED-1, 
C03F11.3 and 
ABL-1 
dependent 
pathways  
(52, 53) 
Drechmeria 
coinospora 
Attachment and 
penetration through 
cuticle 
 (54) 
Table 1.3 C. elegans pathogens. This table was adapted and modified from a previous 
publication and the article is listed for reference (50).  
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C. elegans innate immunity 
Generally speaking, the Innate immune process consists of three steps: 1) Pathogen 
recognition by host receptors; 2) Signal transduction through phosphorylation and transcriptional 
regulation and 3) Production of effectors that achieve immunity. In this section, I will briefly 
discuss current knowledge of the components of the each of these steps.  
 
Pathogen recognition 
During microbial infection on start, host sense the infection through two major 
mechanisms: through the recognition of pathogen associated molecular patterns (PAMPs) (73), 
or though damage associated molecular patterns (DAMPs) (74, 75).  
In C. elegans, the PAMP-associated pathogen recognition pathway has not been well 
defined, largely due to the lack of conserved pattern recognition receptor(s) (PRR) being 
identified in the C. elegans genome. The only Toll-like Receptor homologue, TOL-1, in C. 
elegans is not involved in direct pathogen recognition (76). In addition, C. elegans lacks the 
peptidoglycan receptors or the NOD-like receptors (77). However, studies have shown that both 
live and heat-killed pathogens, i.e. C. albicans and E. faecium, induced similar immune 
responses in C. elegans, suggesting there are mechanisms to recognize pathogen-associated 
patterns (78, 79). In the search for immune receptors, one candidate identified was the G 
protein-coupled receptor FSHR-1 (66). FSHR-1 is a surface protein containing evolutionary 
conserved extracellular leucine-rich repeat (LRR) domain that is present in many other 
pathogen receptors in animals and plants (66).  However, it is unclear whether FSHR-1 directly 
recognizes infection and its pathogen ligand is yet to be identified (66, 80).  
In addition to direct PAMP-recognizing mechanisms, C. elegans can also recognize 
pathogen induced damage and activate downstream immune responses. Examples include 
epidermis and cuticle disruption by physical force, causing activation of the PMK-1 pathway, 
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similar to epidermal fungal infection (81, 82), and pore-forming toxins causing activation of the 
PMK-1 pathway in the intestine (83). More recently, a G protein-coupled receptor (GPCR), 
DCAR-1, was identified as a potential sensor for fungal infection and cuticle defects (84). The 
endogenous ligand of DCAR-1 is thought to be the 4-hydroxyphenyllactic acid (HPLA), a 
tyrosine derivative that has increased presence during infection and cuticle alteration (84).  
 
Signal transduction 
In contrast with the uncertainty and speculation in the pathogen recognition research 
areas, signal transduction pathways in C. elegans are much more well-defined. Two major 
signaling pathways, the p38 MAPK pathway and the DAF-2/DAF-16 insulin signaling pathway, 
have been characterized for their functions during infection and many other stress-related 
responses.  
The p38 MAPK pathway is an evolutionally conserved signaling pathway across diverse 
organisms, regulating not only innate immunity, but also stress responses. It has been well 
studied in yeast and mammals for its involvement in osmotic stress response (85), abiotic stress 
response, and innate immune response (86) (87). In C. elegans, the p38 MAPK pathway is 
activated in the intestine, hypodermis, and neurons during various infections. The core 
components include the MAPK, NSY-1, the MAPKK, SEK-1, and the MAPKKK, PMK-1. Loss of 
PMK-1 result in significant increases in susceptibility of C. elegans to multiple pathogens, 
including Gram-negative bacteria such as P. aeruginosa (71, 88) and S. enterica (68), Gram-
positive bacteria such as E. faecalis (89) and S. aureus (59), and the fungal pathogen C. 
albicans (51). In addition, loss of the upstream components, NSY-1 and SEK-1, also result in 
enhanced killing during P. aeruginosa infection (71, 90).  
The DAF-2/DAF-16 insulin signaling pathway regulates aging, metabolism, and 
development in C. elegans (91). It also plays an important role in innate immunity (61).  DAF-2, 
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the insulin-like receptor, inhibits the activity of the downstream transcription factor DAF-16 
through a cascade of phosphorylation of AGE-1, PDK-1, and AKT-1 (92). Constitutive activation 
of DAF-16 results from loss of function mutations in daf-2 or age-1 resulting in significantly 
increased resistance to multiple pathogens including P. aeruginosa, S. aureus, and E. faecalis 
(61).  
Effector production 
Antimicrobial effector secretion is a frequent result of innate immune signaling and plays 
an important role in pathogen clearance. In C. elegans, there are multiple types of effectors that 
have been demonstrated to have protective roles against pathogens. The saposin-like 
amoebapores (SPPs) and Anti-Microbial Peptides (AMPs) were the first ones to be discovered. 
C. elegans encodes a large number of SPPs that function in multiple tissues including the 
pharynx and the intestine to exert their antimicrobial function. Recombinant SSPs expressed in 
E. coli exhibited microbicidal activity (93). AMPs are antimicrobial peptides encoded by abf-1 
and abf-2 genes (94). They are expressed in the pharynx and the intestine and experiments 
with recombinant protein showed strong antimicrobial activity against bacteria and fungi (94). 
Through expression profiling and sequence homology analysis, lysozymes, another family of 
immune effectors was identified (95). Overexpression of the lys-1 gene increased C. elegans 
resistance to Serratia marcescens (95). Another important effector family is C-type lectins 
(CLEC), many of which are induced during infection and participate in immune defense 
(reviewed in (96) . For example, purified CLEC-39 and CLEC-49 bound to S. marcesecens, and 
mutations in the clec-39 and clec-49 genes resulted in increased susceptibly to this pathogen 
(95, 97).  
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Roles of DUOX and peroxidases in C. elegans innate immunity  
As discussed in the beginning of this chapter, ROS production is one of the first innate 
immune responses upon successful pathogen recognition. In C. elegans, the NADPH dual 
oxidase ce-DUOX1(BLI-3) is the major source of ROS. BLI-3 was first discovered for its critical 
role in cuticle cross-linking and was found to be present in the hypodermis (28). Later, it was 
demonstrated that BLI-3 is responsible for the increased level of H2O2  observed when worms 
are infected by E. faecalis, and RNAi knockdown of BLI-3 result in a significant increase in 
pathogen sensitivity (98, 99). More recently, mCherry::BLI-3 transgene revealed that in addition 
to its hypodermis localization, BLI-3 was also produced in the pharynx and intestine (100). It is 
also shown that BLI-3 generated ROS activates the p38 MAPK pathway, resulting in the nuclear 
localization of stress response regulator SKN-1, a Nrf2 orthologue in mammalian system, and 
activation of detoxification genes (101). In the same study, it was established that SKN-1 is 
required for pathogen resistance. A model was proposed for BLI-3-mediated SKN-1 activation 
(103). Together, these findings implicated a role for ROS production in immune signaling. It also 
highlighted the significant cross-talk and overlap between stress response and innate immune 
pathways.  
Interestingly, while the NADPH oxidase domain of BLI-3 is required for both pathogen 
resistance and cuticle cross-linking functions, the peroxidase domain is dispensable for 
pathogen resistance (99). This led to the speculation that a partner peroxidase might be 
involved. Indeed, a peroxidase, SKPO-1,  which functions in pathogen resistance, was 
discovered (102). Loss of SKPO-1 not only resulted in incomplete penetration of dumpy 
phenotype, but also significantly increased C. elegans susceptibility to E. faecalis, suggesting 
that SKPO-1 plays a role in cuticle cross-linking and pathogen resistance (102). A skpo-1 
mutant produced an even higher level of H2O2 compared to N2 when exposed to pathogen, 
indicating a possible function in H2O2 consumption - perhaps modulating the levels of this 
 19 
oxidant during infection (102). Furthermore, SKPO-1 localizes to the hypodermis of the worm, a 
tissue in which BLI-3 also resides (102). However, whether or not there is a physical interaction 
between BLI-3 and SKPO-1 is unknown.  
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Chapter 2 Materials and Methods 
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Strain Maintenance 
C. elegans strains were grown and maintained as previously described (104). The hpx-2 
nonsense mutation strain VC20223 hpx-2(gk252521) was obtained from the Caenorhabditis 
Genetic Center and was backcrossed with N2 Bristol six times. C. elegans strains, bacterial 
strains, and fungal strains used in this study are listed in Supplemental Material, Table S5. For 
experiments requiring synchronized worms, L1 stage worms on starved plates were washed off, 
filtered through a 10µm filter (pluriSelect, pluriStrainer 10µm) spun down, transferred to seeded 
plates, and grown to the desired stage.  
 
Strain Construction 
To generate the hpx-2(dg047) CRISPR knock-out strain, single guide (sg) sequences 
were designed by WU CRISPR (http://crispr.wustl.edu) using the un-spliced sequence of the 
hpx-2 gene. Four 18 bp sg sequences with WU score higher than 65 were selected and 
separately cloned into pJW1219 (105). A mixture of four plasmid constructs was injected into N2 
worms at a concentration of 10 ng/µl each, and with 10 ng/µl of pJW1219-dpy-10 as a co-
CRISPR marker. Worms that displayed a roller or dumpy phenotype were then isolated for 
genotyping to test for insertions and/or deletions (INDEL) in the hpx-2 gene. Verified hpx-2 
mutants were backcrossed with N2 to eliminate the dpy-10 mutation.  
The HPX-2 catalytic residue mutant (HPX-2-R372A), PHX782 hpx-2(syb782), was 
generated by Suny Biotech (http://www.sunybiotech.com) using CRISPR-Cas9. The mutant 
strain PHX782 hpx-2(syb782) was verified by PCR sequencing and the primers are listed in 
Table S6.  
To generate the hpx-2 complemented strains, a 12 kb DNA fragment containing the hpx-
2 gene and 5 kb of upstream and 4 kb of downstream sequences was amplified from the 
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genomic DNA of N2 worms. The PCR product was then purified and injected into hpx-2(dg047) 
and hpx-2(gk252521) at 20 ng/µl concentration with 50 ng/µl of EcoRV-digested genomic DNA 
from N2 worms. pCFJ90 (pMyo2::mCherry) was used as a fluorescent co-injection marker at a 
final concentration of 2 ng/µl.  
To visualize hpx-2 expression, the GF203 strain was generated by injecting the 
pPD95.75 (50 ng/µl) plasmid containing the 4 kb upstream of hpx-2 and the first two exons 
fused to gfp, with 20 ng/µl pRF4 (rol-6(su1006)) as a roller co-injection marker. The obtained 
strains with extrachromosomal arrays were then exposed to trimethylpsoralen (TMP) with UV 
irradiation and back crossed six times to generate stable integrated transgenic lines using a 
previously described protocol (106). All the oligonucleotide primers used in this study are listed 
in Table S6.  
 
Killing and Longevity Assays  
  Killing assays and longevity assays were conducted as previously described, with some 
slight modifications (61, 62, 107). All assays were done with 30 worms at the L4 stage worms 
on three replica plates (or 6-plate wells for the C. albicans assay) for a total of 90 animals and 
scored for survival over time. For plate preparation, E. faecalis OG1RF was grown in BHI for 5 
hours and seeded onto BHI agar plates with 50 µg/ml of gentamycin and grown overnight at 
37°C. P. aeruginosa PA14 was grown in LB broth overnight and seeded onto SK plates, 
incubated at 37°C for 24 hours, and then 25°C for another 24 hours. S. enterica SL1344 was 
grown in LB overnight and seeded onto SK plates and incubated at 37°C overnight. S. aureus 
NCTC8325, grown in TSB with 10 µg/ml nalidixic acid (Nal) overnight, was seeded to TSA+Nal 
plates and incubated at 37°C for 6 hours. C. diphtheriae NCTC13129 grown in BHI overnight 
was seeded onto BHI plates containing 25 µg/ml Nal and 50 µg/ml 5-fluoro-2-deoxyuridine 
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(FuDR) and incubated at 37°C for 24 hours. C. albicans strain SC5314 was grown overnight in 
BHI media and spotted onto solid BHI plates. L4 stage worms were exposed to C. albicans for 4 
hours and were collected, washed, and transferred to six-well plates containing 20% BHI and 
80% M9W, and scored for survival daily (108). 
 
RNA interference  
To knock down hpx-2 gene expression, L1 to L4 stage larvae were exposed to E. coli 
HT115 containing the expression plasmid for double-stranded hpx-2 previously constructed 
(109). L4 stage worms were then transferred to E. faecalis killing plates for the pathogen 
susceptibility assay.  
 
Fluorescence microscopy 
To visualize HPX-2::GFP expression, worms with the roller phenotype indicative of the 
co-injection marker were picked and anesthetized with 25 mM tetramisole and mounted on 2% 
agarose pads. The worms were then visualized and imaged using Olympus Fluoview FV3000. 
To visualize intestinal colonization by E. faecalis and P. aeruginosa, C. elegans were 
exposed to these pathogens for 48 hours (E. faecalis) and 24 hours (P. aeruginosa) respectively 
on agar plates. They were then washed off the plates and washed four times with 1 ml of M9W. 
Following anesthesia with 25 mM tetramisole hydrochloride, the worms were mounted on 2% 
agarose pads for imaging. 
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Colony forming unit assay of intestinal colonization  
 To measure intestinal CFUs, animals were exposed to bacteria as described above and 
then washed off plates with M9W. They were then washed three times in 1 ml of M9W, then 
twice more with 1 ml of M9W containing 25 mM tetramisole hydrochloride. The worms were 
then treated with 500 µl M9W containing 25 mM tetramisole hydrochloride, 1 mg/ml of ampicillin, 
and 1 mg/ml kanamycin for 1 hour to kill all surface bacteria. The treated worms were washed 
twice more with 1 ml of M9W containing 25 mM tetramisole hydrochloride, transferred to an 
Eppendorf tube containing 100 µl of M9 (one worm per tube), and disrupted using a motorized 
pestle (Kontes cordless pestle (cat# K749540-0000) and pestles (cat# K749521-1590) for 1 min. 
The solution was then serially diluted in M9 and spotted on agar plates for CFU counting.  
 
Hoechst staining  
 Hoechst staining of the worms was performed as previously described (110). 
Specifically, worms were washed off plates with M9W buffer, and then incubated in M9W 
containing 1 mg/ml Hoechst 33258 dye (Sigma) at room temperature for 20 minutes with gentle 
shaking, followed by three more washes with M9W before imaging. Hoechst-positive worms 
were scored based on staining of the epithelial cell nuclei, which is indicative of cuticle 
penetration.  
 
RNA isolation and qRT-PCR analysis 
 L4 animals were exposed for 16 hours to the condition of interest and total RNA was 
extracted using Trizol (Invitrogen) according to the manufacturer’s instructions. RNA samples 
were treated with Turbo DNA free kit (Applied Biosystems) to eliminate DNA contamination. 
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qRT-PCR was performed as previously described (101). The actin gene was used as an internal 
control. Primers used in qRT-PCR are listed in Table S7. 
 
RNA sequencing  
 L4 stage worms were exposed to E. faecalis or E. coli for 16 hours and total RNA was 
extracted for 5 biological replicates. Illumina Hiseq 4000 sequencer with 75 nt pair-ended read 
format was used to conduct the sequencing. The sequencing reads (ranging from 20 million to 
37 million per biological replicate) were quality and adaptor trimmed and mapped to the 
reference genome (version WBcel235 downloaded from http://ensemblgenomes.org) using 
Tophat (111). The expression level (RPKM) of annotated genes was measured using Cufflink 
(112), and differential expression analysis was conducted using Cuffcompare and Cuffdiff (112) 
using the gene annotation (Caenorhabditis_elegans.WBcel235.37.gff3 downloaded from 
http://ensemblgenomes.org). Gene Ontology analysis was carried out by using DAVID (the 
Database for Annotation, Visualization, and Integrated Discovery) 6.8 (113). Gene enrichment 
with a Benjamini adjusted P < 0.05 is listed. Genes that were differentially regulated under 
different conditions are listed in Table S1-4. 
 
Amplex Red Assay 
To measure H2O2 concentration of the worms, the Amplex red assay was performed as 
previously described (109) using the Amplex Red hydrogen peroxide/peroxidase kit (Invitrogen 
Molecular Probes, Eugene, OR) with the following modifications: L4 worms were exposed to a 
bacterial strain for 16 hours and transferred to 96 well plates with 30 worms in each well. A total 
of 80 mM diphenyleneiodinium chloride (DPI) (TCI, Tokyo) was added to some wells and 
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allowed to incubate for 15 minutes prior to addition of Amplex Reagents. After 1 hour of 
incubation, fluorescence was measured at 540/590 nm excitation and emission, respectively.	 
 
Pharyngeal pumping Rate  
To measure the pharyngeal pumping rate of the worms, contractions of the posterior 
pharyngeal bulb were observed and counted over a 10 second interval for 15 adult animals 
under a 20X magnification stereo microscope.  
 
Brood size  
To measure the brood size of the worms, 9 L4 stage worms were singled on NGM 
plates, allowed to lay eggs and transferred to a new plate each day until no more eggs were 
produced. The offspring on the plates were counted to calculate brood size.  
 
Statistical Analysis  
Survival, longevity assays, qRT-PCR, intestinal CFU, and Hoechst staining data were 
analyzed using GraphPad Prism version 5.0 (GraphPad Software, San Diego). Kaplan-Meier 
log rank analysis was used to compare longevity and survival curves. An unpaired Student’s t-
test was used to determine the statistical significance of the intestinal CFU and Hoechst staining 
data. In all the experiments, P-values < 0.05 were considered to be significant and are noted in 
the figures with one asterisk indicating P < 0.05, two indicating P < 0.01, three indicating P < 
0.001 and four indicating P < 0.0001. 
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Strains Description References 
Enterococcus faecalis    
OG1RF Wild-type strain, FaR, RfR (114) 
OG1RF-GFP  (115) 
Pseudomonas aeruginosa    
PA14 Wild-type strain (116)  
PA14-dsRed Expresses dsRed (117) 
Escherichia coli    
OP50 Wild-type strain, StrR (49) 
HT115(DE3) Used to express dsRNA for 
RNAi in C. elegans, AmpR, 
TetR 
(71) 
EHEC O157:H7 Outbreak strain (118, 119) 
Candida albicans    
SC5314 Wild-type prototrophic strain (120) 
Staphylococcus aureus   
NCTC 8325 Prototypical strain  (121) 
Salmonella enterica   
SL1344  (122) 
Corynebacterium 
diphtheriae  
  
NCTC 13129  (123) 
Caenorhabditis elegans   
N2 Wild-type  (49) 
Hypodermal RNAi strain  Tissue-specific RNAi strain, 
rde-1(ne129); Is[wrt-
2prom::RDE-1::unc-54 3’ 
utr; myo2p::RFP3] 
(124) (124) 
Intestinal RNAi strain  Tissue-specific RNAi strain, 
sid-1(qt9); Is[vha-6::sid-1] 
(124) (124) 
GF200 hpx-2 nonsense mutation 
strain, hpx-2 (gk252521) V 
backcrossed 6 time from 
VC20223  
This study  
GF201 hpx-2 CRISPR/Cas9 
knockout strain, hpx-
2(dg047) V 
This study  
GF202 hpx-2::gfp expression 
strain, dgIs049 [hpx-2p::gfp; 
rol-6(su1006)] 
This study 
GF203 hpx-2 complementation 
strain, hpx-2 (dg047) V; 
dgEx050 [hpx-2p::hpx-2; 
myo-2p::mCherry] 
This study 
GF204 hpx-2 complementation 
strain, hpx-2 (gk252521) V; 
dgEx050 [hpx-2p::hpx-2; 
myo-2p::mCherry] 
This study 
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GF205 hpx-2 overexpression 
strain, hpx-2 (dg047) V; 
dgEx050 [hpx-2p::hpx-2; 
myo-2p::mCherry] 
This study 
GF206 hpx-2 overexpression 
strain, hpx-2 (gk252521) V; 
dgEx050 [hpx-2p::hpx-2; 
myo-2p::mCherry] 
This study 
PHX782  hpx-2(syb782) This study 
 
Table 2.1 Strains used in this study. 
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Ss# Oligo name  Oligo sequence Purpose  
40  P1-sg1-
pJW1219-F 
cct cct att gcg aga tgt ctt g CCA ATG AAG TCA 
TTG AAA GA gtt taa gag cta tgc tgg aaa c 
Clone hpx-2 single 
guide sequence 
#1 to pJW1219 41 P1-sg1-
pJW1219-R 
gtt tcc agc ata gct ctt aaa c TCT TTC AAT GAC 
TTC ATT GG caa gac atc tcg caa tag gag g 
42  P1-sg2-
pJW1219-F 
cct cct att gcg aga tgt ctt g CGG TTA TTG CAG 
TTA ATT GG gtt taa gag cta tgc tgg aaa c 
Clone hpx-2 single 
guide sequence 
#2 to pJW1219 43  P1-sg2-
pJW1219-R 
gtt tcc agc ata gct ctt aaa c CC AAT TAA CTG 
CAA TAA CCG c aag aca tct cgc aat agg agg 
44 P1-sg3-
pJW1219-F 
cct cct att gcg aga tgt ctt g CTT CGA TTC GAT 
CAA TCA CA gtt taa gag cta tgc tgg aaa c 
Clone hpx-2 single 
guide sequence 
#3 to pJW1219 45 P1-sg3-
pJW1219-R 
gtt tcc agc ata gct ctt aaa c TG TGA TTG ATC 
GAA TCG AAG c aag aca tct cgc aat agg agg 
46  P1-sg4-
pJW1219-F 
cct cct att gcg aga tgt ctt g ATG CAG CTC CCA 
GAA TTC GG gtt taa gag cta tgc tgg aaa c 
Clone hpx-2 single 
guide sequence 
#4 to pJW1219 47 P1-sg4-
pJW1219-R 
gtt tcc agc ata gct ctt aaa c CC GAA TTC TGG 
GAG CTG CAT c aag aca tct cgc aat agg agg 
205 pHPX2-4kb-
9567-F 
GCCTGCAGGTCGACTtacttcttttgtaaattctcctgtatg
aactttttgtg 
Clone 4kb 
promoter region of 
hpx-2(plus first 5 
aa) into pPD95.67 
206 pHPX2-4kb-
9567-R 
CCGGGGATCCTCTAGcggtttcaaattcatatttcaaaa
tgaattctaaataatcgg 
212 HPX2-12KB-
pBluescript-F 
cactagttctagagcggaagtcattgatcaacccgtgag Gibson assembly 
of 10KB HPX-2 
fragment into 
pBluescript 
213 HPX2-12KB-
pBluescript-R 
accgcggtggcggcccttgtgtgctcttgtaaaatcgcaagc 
257 YL01-seq-s AACTACCGTCTGCTAGGCTA PCR and 
sequencing 
primers for HPX-2-
R372A (syb482) 
258 YL01-seq-a1 TAGATGGATCTACACTGGTAC  
 
 
Table 2.2 Oligonucleotides used in this study. 
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act-1 F ACC ATG TAC CCA GGA ATT GC  
act-1 R TGG AAG GTG GAG AGG GAA G  
lys-1 F CCACAGGACAACTTCGAAGTGACT 
lys-1 R TGTCTTGAGGCAGTTCATTTGAGAAACT 
lys-2 F CGCTTCAATGGGAAATGCTGTCG 
lys-2 R CCAACACAATTTGAATCAAAAGCTCCATTT 
lys-3 F CTCTATTACATTGTGCTACTCTTTCC 
lys-3 R TCATCATATGGAATTGCTGGAGC 
lys-7 F TGCATACAACCCAGCAGG 
lys-7 R ATGATCTCATCCAACTGTTGGT 
spp-20 F CATATTTGCCAGCTTGCTCC 
spp-20 R CAACAAATTGAGAGACGAGTACAC 
f53a9.8 F GTCGCACCAAGAACACGGAC 
f53a9.8 R GCCTGATGGTTGCCCCC 
pmk-2 F GGCGATTCAGCCAGCATTCCCG 
pmk-2 R CTCCATACGCTCCTTCTCCTAGAGGC 
col-20 F CTATCATTGCCGTGCCAATG 
col-20 R GATCAGAAACAGCGTTAGATCG 
col-88 F TGATGCCTGGAGATCCATG 
col-88 R GGTCCTGGTGGTCCG 
hsp12.3 F CTGGACTACGAAGACCATTTC 
hsp12.3 R AATACTGCGGGTGATAGATCC 
 
Table 2.3 Primers used in qRT-PCR 
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Chapter 3 HPX-2 contributes to pathogen resistance in C. elegans 
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Introduction 
When exposed to pathogen, production of Reactive Oxygen Species (ROS) is one of the 
first innate immune responses initiated by the host. ROS can exert immune-protective effects by 
acting directly as an antimicrobial, serving as a signal to activate downstream responses, and/or 
contributing to the generation of physical barriers. There are two major groups of enzymes 
involved in this process – the ROS producing NADPH oxidases/Dual-oxidases (NOX/DUOX) 
and the ROS utilizing, heme-containing peroxidase (reviewed by 22, 125)). In many cases, 
these enzymes are functionally, and sometimes physically linked to contribute to innate 
immunity against pathogen. The most canonical case studied in mammalian systems is that of 
myeloperoxidase (MPO), which resides in the phagolysosome of macrophages and utilizes the 
superoxide produced by NOX2 to generate the powerful oxidant HOCl during the oxidative burst 
that occurs as a result of microbial engulfment (reviewed by (126)). Additionally, it has been 
shown that lactoperoxidase (LPO) coupled with DUOX2, is responsible for the generation of the 
antibiotic oxidant hypothiocyanite (OSCN-) from H2O2 and thiocyanate (SCN-) on mucosal 
surfaces (16, 18, 127). These responses are not limited to animals; plants also employ 
peroxidases and NADPH oxidases as part of their antimicrobial arsenal (reviewed in (128)).  
In C. elegans, the one functional NOX/DUOX encoded by the genome is BLI-3, a dual 
oxidase that produces H2O2 when animals are exposed to pathogen (28, 98, 99, 129). Like all 
dual oxidases, BLI-3 consists of an NADPH oxidase domain and a heme peroxidase domain 
(28). The production of H2O2 from the NADPH oxidase domain of BLI-3 is required for pathogen 
resistance and point mutants that affect this domain significantly increase pathogen 
susceptibility (99, 100). In addition to its role during infection, BLI-3 is crucial for cuticle 
development. The peroxidase domain uses the H2O2 produced by the NADPH oxidase domain 
to cross-link collagen proteins (28). Another independent heme-binding peroxidase, MLT-7, 
additionally contributes to this process (29). Mutations in the peroxidase domains of BLI-3 and 
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MLT-7 that impair activity result in a blistered phenotype. However, these mutations do not 
affect pathogen susceptibility (102).  
Given that NOX/DUOX enzymes and heme-containing peroxidases often functionally 
partner, we hypothesized that there might be DUOX-Peroxidase systems in C. elegans that 
contribute to pathogen resistance. To test this hypothesis, a previous graduate student in our 
lab, Dr. George Tiller, conducted a RNAi screen where he knocked down each of all the putative 
peroxidases encoded in C. elegans genome and tested their susceptibility to E. faecalis (102). 
He found three putative peroxidases that when knocked down significantly increase pathogen 
susceptibility. One, which he named SKPO-1, was characterized in detail in his Ph.D. 
dissertation (102). He showed that a skpo-1 mutant was more susceptible to E. faecalis 
compared to the N2 reference strain. In addition to pathogen sensitivity, the skpo-1 mutant also 
had an incomplete penetrance of dumpy phenotype, suggesting a potential role in the process 
of cuticle bio-generation. Interestingly, SKPO-1 localized to the hypodermis of the worm, a 
tissue where BLI-3 also resides, indicating a potential physical interaction between the two 
(102). Despite the functional and spatial overlap of the DUOX BLI-3 and the heme-peroxidase 
SKPO-1, questions remain regarding how this peroxidase and others function in a protective 
role against pathogens.  
Here, I characterized the other two immune-protective peroxidases, F09F3.5 and 
F08F11.7, which I named HPX-2 and HPX-3 respectively for Heme Peroxidase 2 and 3. Using a 
combination of RNA interference (RNAi) and CRISPR-Cas9 mediated gene inactivation 
approcaches, I demonstrated that HPX-2 is important for protecting C. elegans against some, 
but not all, pathogens. 
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Results 
RNAi of the putative peroxidases results in susceptibility to E. faecalis 
To verify the protective role of the putative peroxidases against pathogen, I utilized RNA 
interference experiments to knock down HPX-2 and HPX-3. The RNAi constructs were available 
in the RNAi library (130), (131). The RNAi-treated animals were exposed to E. faecalis and 
scored for survival over time. Consistent with previous findings, reduced expression of hpx-2 
and hpx-3 resulted in a significant increase in pathogen susceptibility (Figure 3.1) (102).  
 
Generation of CPRSR/Cas9 mutants of the putative peroxidases  
To further study the function of the two putative peroxidases, I generated the truncated 
mutant alleles of hpx-2 and hpx-3 through CRISPR-Cas9 mediated gene editing (Figure 3.2). 
After PCR and sequencing for verification, one allele was obtained for each gene: hpx-2(dg047) 
and hpx-3(dg048). The changes in DNA sequence are listed in Figure 3.3. Both alleles had 
insertions and deletions (INDELS) at the 5’ end of the genes, resulting in the translated product 
missing most of the predicted peroxidase domain and are therefore predicted loss-of-function 
mutants (Figure 3.4). In addition to the CRISPR mutant, I was also able to obtain a nonsense 
mutant allele of hpx-2 (hpx-2(gk252521)) from the Caenorhabditis Genetic Center (GCG) 
(Figure 3.4). The EMS-generated mutant was backcrossed with the N2 strain six times to 
eliminate background mutations.    
After exposure to E. faecalis, I observed significant increases in the susceptibility of both 
hpx-2 mutants (hpx-2(dg047) and hpx-2(gk252521)) to the pathogen which were more dramatic 
than the RNAi-treated strain (Figure 3.6). However, in contrast with the RNAi result, no 
significant changes in pathogen susceptibility from hpx-3(dg048) was observed (Figure 3.7). To 
independently verify this result, I constructed one more allele of hpx-3 (hpx-3(dg049)) and 
tested the strain’s pathogen sensitivity by exposing it to E. faecalis (Figure 3.5). The newly 
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generated mutant allele of hpx-3 also did not exhibit pathogen sensitivity compared to the N2 
strain (Figure 3.7). I hypothesized that the RNAi construct of hpx-3 used in the previous 
experiments might have off-target effects, resulting in a false pathogen sensitivity phenotype. 
Indeed, close examination of the sequence of the RNA construct revealed significant sequence 
homology to the hpx-2 gene. It is likely that the hpx-3 RNAi construct had an off-target effect on 
the hpx-2 gene causing a false positive result. Hence, I focused my project solely on HPX-2.  
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Figure 3.1 Survival of worms on E. faecalis OG1RF following exposure to vector control 
(VC) RNAi, (A) hpx-2 RNAi and (B) hpx-3 RNAi. Representative results from one experiment 
with an n of approximately 90 worms for each condition are shown. Median survival and P-
values are listed in Table 3.1 as experiment No.1 along with other biological replicates.  
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Figure 3.2 Microinjection and screen for CRISPR mutants. Four single guide (sg) sequences 
designed by WU CRISPR (http://crispr.wustl.edu) using the un-spliced sequence of the hpx-2 or 
hpx-3 gene were cloned into pJW1219 (105). A mixture of four plasmid constructs were injected 
into N2 worms at a concentration of 10 ng/µl each, and with 10 ng/µl of pJW1219-dpy-10 as a 
co-CRISPR marker. Worms that displayed a roller or dumpy phenotype were then isolated for 
genotyping to test for insertions and/or deletions (INDELs) in the targeted genes. Verified 
CRISPR mutants were backcrossed with N2 to get rid of the dpy-10 mutation.  
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Figure 3.3 DNA sequence of HPX-2 and HPX-3 CRISPR mutants. Blue letters indicate single 
guide sequences, Grey and underlined letters indicate PAM sequences, red indicates the 
changed sequence in the mutants. 
 
 
 
 
 
 
 
 
hpx-2 (dg047) mutation results in  a stop codon at down stream which produce 150aa 
truncated version of P1 transcript 543 bp, truncated protein ~17.1 KD
WT 5’    …CCA CCA AT - - - - - -TAACTGCAATAACCG ATTC…   3’
hpx-2 (dg047)        5’   …CCA CCA ATCCACCA - - - - - GCAATAACCG ATTC…  3’
Sequencing results of CRISPR mutants 
WT 5’    …. AGA AATTCTGGAGAG - - - - - - - - CAACAGGGTG GAGGT…3’
hpx-3 (dg048)        5’   … AGA AATTCTGGAGAGATTCTGGA - - - - - - - - - - - GAGGT…3’
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Figure 3.4 Schematic representation of HPX-2 mutants. Wilde-type HPX-2 protein is 
composed of 718 amino acids, with the predicted peroxidase domain at the C-terminus. hpx-
2(dg047) allele harbors an INDEL mutation at its N-terminus, resulting in a frameshift and 
premature stop for protein translation. The predicted protein length is 210 amino acids. The hpx-
2(gk252521) allele has an amber mutation at its N-terminus, resulting in a truncated 133 amino 
acid protein.  
 
 
 
 
 
 
HPX-2 truncated mutants
An_peroxidase domain
1                158                                                     696   718   
1             133   
1                 158  210   
N2
hpx-2(dg047)
hpx-2(gk252521)
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Figure 3.5 Schematic representation of HPX-3 mutants. Wild-type HPX-3 protein is 
composed of 773 amino acids, with the predicted peroxidase domain at the C-terminus. hpx-
3(dg048) allele harbors an INDEL mutation at its N-terminus, resulting in a frameshift and 
premature stop for the translated protein. The predicted protein length is 227 amino acids. The 
hpx-3(dg049) allele has an has an INDEL mutation at its N-terminus, resulting in a frameshift 
and premature stop for the translated protein. The predicted protein length is 234 amino acids.  
 
 
 
 
 
 
 
An_peroxidase domain
1                189                                                       752   773   
1                 189  234   
N2
hpx-3 (dg049)
R08F11.7 CRISPR mutants
1                 189  227   
hpx-3 (dg048)
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Figure 3.6 Survival of hpx-2 mutants on E. faecalis. Results from one representative 
experiment with an n of approximately 90 worms for each condition are shown. Median survival 
and P-values are listed in Table 3.1 as experiment No.1 along with other biological replicates.  
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Figure 3.7 Survival of hpx-3 mutants on E. faecalis.  Results from one representative 
experiment with an n of approximately 90 worms for each condition are shown. Median survival 
and P-values are listed in Table 3.1 as experiment No.1 along with other biological replicates.  
 
 
 
 
 
 
 
 
 
 
 
 
A B 
n.s. n.s. 
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Hpx-2 mutants showed no general fitness defects  
To ensure that the pathogen sensitivity phenotype of hpx-2 mutants was not due to an 
impairment in general fitness of the worms, the mutants were tested for general defects in 
fitness by measuring their longevity on live (Figure 3.8A) and heat-killed E. coli OP50 (Figure 
3.8B). While both mutants showed slight longevity defects compared with the N2 strain on live 
E. coli, there was no significant difference on heat-killed E. coli. The minor longevity defect of 
the mutants on live E. coli OP50 might result from the slight pathogenicity of OP50 towards 
worms as they age (132). Next, the mutants were tested on vancomycin inactivated E. faecalis 
for survival. Although both mutant alleles showed significantly decreased survival on live E. 
faecalis compared to N2 worms (Figure 3.6), the difference disappeared when worms were 
exposed to E. faecalis inactivated by vancomycin treatment (Figure 3.9), suggesting live 
bacteria were required for killing, and again indicating that the animals do not have a general 
fitness defect. 
In addition to wild-type survival rates on non-pathogenic bacteria, the hpx-2 mutants also 
exhibited normal morphology and brood size compared to N2 wild type (Figure 3.10 and 3.11). 
Overall, these data suggest that the loss of HPX-2 does not dramatically affect the fitness of the 
worms.  
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Figure 3.8 HPX-2 does not contribute to the overall fitness of the worm on E. coli. Survival 
of N2 and hpx-2 mutants on (A) E. coli OP50 and (B) heat-killed E. coli OP50. Results from one 
representative experiment with an n of approximately 90 worms for each condition are shown. 
Median survival and P-values are listed in Table 3.1 as experiment No.1 along with other 
biological replicates.  
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Figure 3.9 HPX-2 does not contribute to the overall fitness of the worm on vancomycin 
inactivated E. faecalis. Results from one representative experiment with an n of approximately 
90 worms for each condition are shown. Median survival and P-values are listed in Table 3.1 as 
experiment No.1 along with other biological replicates.  
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Figure 3.10 hpx-2 mutant adults exhibit the same average size and morphology of N2 
worms.  Young adult worms of N2, hpx-2(dg047), and hpx-2 (gk252521) were collected and 
observed under the light microscopy. Images are representative of >100 worms observed.  
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Figure 3.11 hpx-2 mutants have comparable brood sizes compared to N2 worms. Phpx-
2(dg047) =0.2430, n = 9. Error bars represent the SEM, and P-values were calculated via Student’s 
paired t-test. Data are representative of three independent replicates. 
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HPX-2 protects C. elegans from some but not all pathogens  
To test if the pathogen susceptibility of the hpx-2 mutants is pathogen-specific, I 
exposed them to multiple human pathogens including the fungal pathogen Candida albicans 
SC5314 (Figure 3.12 A), Gram-positive pathogens Staphylococcus aureus NCTC8325 (Figure 
3.12 B) and Corynebacterium diphtheriae NCTC12129 (Figure 3.12 C), and finally Gram-
negative pathogens Pseudomonas aeruginosa PA14 (Figure 3.12 D), Escherichia coli O157:H7 
Sakai (EHEC; Figure 3.12 E), and Salmonella enterica SL1344 (Figure 3.12 G). Interestingly, 
hpx-2 mutants showed susceptibility to all the microbial pathogens tested except for the Gram-
negative bacteria, raising the possibility that differences in microbial cell wall structure might 
impact the phenotype observed with loss of hpx-2 (see Discussion).  
hpx-2 mutants can be complemented with genomic DNA containing hpx-2 gene  
To verify that HPX-2 is required for pathogen resistance, I complemented the mutant 
strains with DNA containing the hpx-2 gene and subjected the animals to E. faecalis exposure. 
Specifically, a 12-kb DNA fragment was PCR amplified from the genomic DNA of N2 worms. 
The fragment was purified and injected into both mutant alleles at a concentration of 20 ng/µl 
with Pmyo-2::mcherry (2 ng/µl) as a co-injection marker. When exposed to E. faecalis, the 
complemented strains showed a significant increase in pathogen tolerance compared to the 
parental strains, reaching a level of resistance similar to N2 (Figure 3.13 A and B). These data 
collectively suggest that HPX-2 is required for resistance to many, but not all, pathogens 
capable of infecting C. elegans.  
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Figure 3.12 HPX-2 contributes to C. elegans resistance to some pathogens. Survival of N2 
and hpx-2 mutants on (A) Candida albicans SC5314, (B) Staphylococcus aureus NCTC8325, 
(C) Corynebacterium diphtheriae NCTC12129, (D) Pseudomonas aeruginosa PA14, (E) 
Escherichia coli O157:H7 Sakai (EHEC), and (F) Salmonella enterica SL1344. Results from one 
representative experiment with an n of approximately 90 worms for each condition are shown. 
Median survival and P-values are listed in Table 3.1 as experiment No.1 along with other 
biological replicates. 
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Figure 3.13 Genomic hpx-2 complementation rescues the susceptibility to E. faecalis. (A) 
Survival of N2, hpx-2(dg047) mutant, and its complemented strain on E. faecalis. (B) Survival of 
N2, hpx-2(gk252521) mutant, and its complemented strain on E. faecalis. The hpx-2 mutants 
are set as control. Results from one representative experiment with an n of approximately 90 
worms for each condition are shown. Median survival and P-values are listed in Table 3.1 as 
experiment No.1 along with other biological replicates. 
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Figure 
number 
Experiment 
number  
Strain Exposure 
conditions  
Median 
survival 
(days) 
P-value  
3.1 A 1 N2 VC RNAi E. faecalis 5 C 
  N2 hpx-2 RNAi E. faecalis 3 0.0029 
 2 N2 VC RNAi E. faecalis 5 C 
  N2 hpx-2 RNAi E. faecalis 4 0.007 
3.1 B 1 N2 VC RNAi E. faecalis 6  
  N2 hpx-3 RNAi E. faecalis 5 0.0042 
 2 N2 VC RNAi E. faecalis 7  
  N2 hpx-3 RNAi E. faecalis 6 0.0233 
3.6  1 N2  E. faecalis 6 Control (C) 
  hpx2 (dg047) E. faecalis 4 <0.0001 
  hpx-2 (gk252521)  E. faecalis 4 <0.0001 
 2 N2  E. faecalis 5 C 
  hpx2 (dg047) E. faecalis 4 0.0036 
  hpx-2 (gk252521)  E. faecalis 4 0.0016 
3.7 A 1  N2 E. faecalis 5 C 
  hpx-3(dg048) E. faecalis 5 0.1834 
 2 N2 E. faecalis 5 C 
  hpx-3(dg048) E. faecalis 5 0.8783 
3.7 B 1 N2 E. faecalis 5 C 
  hpx-3(dg049) E. faecalis 5 0.1093 
 2  N2 E. faecalis 5 C 
  hpx-3(dg049) E. faecalis 5 0.5014 
3.8 A 1 N2  E. coli 22 C 
  hpx2 (dg047) E. coli 20 0.0257 
  hpx-2 (gk252521)  E. coli 21 0.0115 
 2 N2  E. coli 22 C 
  hpx2 (dg047) E. coli 20 0.014 
  hpx-2 (gk252521)  E. coli 20 0.026 
3.8 B 1 N2  Inactivated E. coli 23 C 
  hpx2 (dg047) Inactivated E. coli 23 0.4918 
  hpx-2 (gk252521)  Inactivated E. coli 24 0.8962 
 2 N2  Inactivated E. coli 21 C 
  hpx2 (dg047) Inactivated E. coli 21 0.4737 
  hpx-2 (gk252521)  Inactivated E. coli 21 0.9988 
3.9 1 N2  Inactivated E. 
faecalis 
10 C 
  hpx2 (dg047) Inactivated E. 
faecalis 
10 0.2266 
  hpx-2 (gk252521)  Inactivated E. 
faecalis 
10 0.8574 
 2 N2  Inactivated E. 
faecalis 
10 C 
  hpx2 (dg047) Inactivated E. 
faecalis 
10 0.3007 
  hpx-2 (gk252521)  Inactivated E. 
faecalis 
11 0.1732 
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3.12 A  1 N2  C. albican  12 C 
  hpx2 (dg047) C. albican 10 0.0004 
  hpx-2 (gk252521)  C. albican 9 <0.0001 
 2 N2  C. albican 10 C 
  hpx2 (dg047) C. albican 8 0.0089 
  hpx-2 (gk252521)  C. albican 8 0.0029 
3.12 B 1 N2  S. aureus 4 C 
  hpx2 (dg047) S. aureus 3 <0.0001 
  hpx-2 (gk252521)  S. aureus 3 <0.0001 
 2 N2  S. aureus 4 C 
  hpx2 (dg047) S. aureus 3 0.008 
  hpx-2 (gk252521)  S. aureus 3 <0.0001 
3.12 C 1 N2  C. diphtheriae 4 C 
  hpx2 (dg047) C. diphtheriae 4 0.0004 
  hpx-2 (gk252521)  C. diphtheriae 4 0.001 
 2 N2  C. diphtheriae 4 C 
  hpx2 (dg047) C. diphtheriae 4 0.0003 
  hpx-2 (gk252521)  C. diphtheriae 4 0.0007 
3.12 D 1 N2  P. aeruginosa 3 C 
  hpx2 (dg047) P. aeruginosa 3 0.8260 
  hpx-2 (gk252521)  P. aeruginosa 3 0.3605 
 2 N2  P. aeruginosa 2 C 
  hpx2 (dg047) P. aeruginosa 2 0.9207 
  hpx-2 (gk252521)  P. aeruginosa 2 0.9896 
3.12 E 1 N2  EHEC 15 C 
  hpx2 (dg047) EHEC 15 0.0586 
  hpx-2 (gk252521)  EHEC 15 0.0516 
 2 N2  EHEC 15 C 
  hpx2 (dg047) EHEC 15 0.9479 
  hpx-2 (gk252521)  EHEC 15 0.4300 
3.12 F 1 N2  S. enterica 6 C 
  hpx2 (dg047) S. enterica 6 0.1765 
  hpx-2 (gk252521)  S. enterica 6 0.8918 
 2 N2  S. enterica 6 C 
  hpx2 (dg047) S. enterica 6 0.2610 
  hpx-2 (gk252521) S. enterica 6 0.4413 
3.13 A 1 hpx-2 (dg047) E. faecalis 3 C 
  N2 E. faecalis 5 <0.0001 
  hpx2 (dg047) 
complemented 
E. faecalis 4 <0.0001 
 2 hpx-2 (dg047) E. faecalis 3 C 
  N2 E. faecalis 4 <0.0001 
  hpx2 (dg047) 
complemented 
E. faecalis 4 0.0012 
3.13 B 1 hpx-2 (gk252521) E. faecalis 3 C 
  N2 E. faecalis 4 <0.0001 
  hpx2 (gk252521) 
complemented 
E. faecalis 4 <0.0001 
 2 hpx-2 (gk252521) E. faecalis 3 C 
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  N2 E. faecalis 4 <0.0001 
  hpx2 (gk252521) 
complemented 
E. faecalis 3 <0.0001 
 
 
Table 3.1 Median survival and P-values in killing assays 
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Discussion 
In this chapter, I characterized a putative heme peroxidase, HPX-2, that contributes to 
resistance to multiple pathogens in C. elegans. Base on previous work from our lab, I started my 
investigation examining two putative peroxidases (HPX-2 and HPX-3) in C.elegans genome that 
when knocked-down by RNAi render C. elegans susceptible to E. faecalis (102). Upon the 
generation of CRISPR knockout mutants of these two peroxidases, I found that one of them, 
HPX-3, does not contribute to pathogen resistance, and the RNAi results were likely due to off-
target effect. Hence, I have focused the remainder of my dissertation on HPX-2.  
I first demonstrated that loss of HPX-2 did not affect the overall fitness of the worms as 
reflected by the normal overall morphology, brood size, and survival rate on E. coli compared to 
N2 strain. In contrast, the two previously identified peroxidases, SKPO-1 and MLT-7, both had 
impacts on the morphology of C. elegans when knocked down or mutated (29, 102). 
Specifically, the SKPO-1 mutant exhibited an incomplete penetration of dumpy phenotype (102). 
It also exhibited a significantly smaller brood size and slower growth compared to the N2 strain 
(102) (unpublished data). MLT-7, on the other hand, exhibits a severe blistered phenotype when 
mutated because of its essential role in cuticle cross-linking (29). Overall, the data suggest that 
HPX-2 is not likely to be heavily involved in the morphogenesis of the worm cuticle (discussed in 
more detail in Chapters 4 and 5). 
Next, I showed that HPX-2 protects worms from Gram-positive bacteria and fungi, but 
not Gram-negative bacteria. The pathogens I tested included C. albicans SC5314, 
Staphylococcus aureus NCTC8325, Corynebacterium diphtheriae NCTC12129, Pseudomonas 
aeruginosa PA14, Escherichia coli O157:H7 Sakai (EHEC), and Salmonella enterica SL1344. 
The reasons I chose those microbes are as follows:  First, they represent a wild-range of 
pathogenic microbes spanning from prokaryotes to eukaryotes.  Second, they are all well 
characterized human pathogens with important clinical relevance. Last but not least, they have 
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been shown to be pathogenic to C. elegans following colonization of the intestines.  As to why 
hpx-2 mutants were more susceptible to fungal and Gram-positive pathogen but not the Gram-
negative, I hypothesize that it is because of the difference in their cell wall structure. Yeast and 
Gram-positive bacteria have thick and hard to disrupt cell walls compared to Gram-negatives. 
As mentioned in the introductory chapter, the pharyngeal grinder of the worm disrupts most 
bacteria through chemical and physical mechanisms, serving as the first defense against 
intestinal colonization. Given the fact that HPX-2 is produced in the pharynx of the worm (see 
next chapter for detail), it might play an important role in assisting the pharyngeal disruption of 
microbial cell wall during feeding.  It could also be that different pathogens have different modes 
of killing, and the mechanism of HPX-2 action might be protective against some modes but not 
others. To lessen this possibility, I made sure that I was using pathogens with similar infection 
sequelae. For all these pathogens, intestinal colonization is a prerequisite for infection. 
Specifically, I used the slow-killing assay to assess P. aeruginosa pathogenesis, which has 
been shown to require intestinal colonization as compared to fast-killing, which is toxin 
mediated. Additionally, I used the shiga toxin-negative strain of EHEC to infect C. elegans, 
which also requires intestinal colonization for killing.   
In conclusion, I report a putative peroxidase, HPX-2, protects C. elegans from fungal and 
Gram-positive pathogen infection, and that loss of HPX-2 does not affect overall fitness of the 
worm. This highlights the immune-specific function of peroxidases in the worm. 
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Chapter 4: HPX-2 functions in pharynx and hypodermis as a putative peroxidase for 
pathogen resistance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 57 
Introduction 
In Chapter 3, I showed that HPX-2 provides protection from many, but not all pathogen 
infections. In order to further study the function of HPX-2 in innate immune protection, I decided 
to investigate its localization and enzymatic function.  
The only functional NOX/DUOX, BLI-3, was first shown to be localized to the hypodermis 
using immune-staining, which is consistent with its function in cuticle cross-linking (28). Later, a 
study from our lab showed that BLI-3 might also be present in the intestine and involved in 
pathogen resistance since intestinal-specific RNAi knockdown of BLI-3 resulted in increased 
susceptibility to E. faecalis (99). More recently, through the construction of a BLI-3::mCherry 
transgene,  BLI-3 was localized to the pharynx in addition to the intestine and the hypodermis 
(100). It was also shown that BLI-3 is involved in protecting worms from C. albicans infection in 
addition to E. faecalis infection, although the amount and pattern of BLI-3 localization did not 
change upon exposure to these pathogens (101).  
Given that DUOXs often pair with peroxidases for their function, I postulated that 
peroxidases that functionally interact with BLI-3 are likely to be in one or more of the tissues that 
harbor BLI-3. Indeed, a previous study from our lab demonstrated that SKPO-1, another 
immune-protective peroxidase, localizes to the hypodermis (102). Considering that HPX-2 is 
also likely to functionally interact with BLI-3, I tested the hypothesis that it has a similar 
expression/ localization pattern and is likely to be found in pharynx, gut and/or hypodermis. 
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Results 
HPX-2 localizes to pharynx and hypodermis of the worms  
To functionally localize HPX-2, I conducted tissue-specific RNAi to knock down hpx-2 in 
the intestine or hypodermis and measured the worms’ susceptibility to E. faecalis. I observed 
that intestinal RNAi did not affect pathogen susceptibility, whereas hypodermal RNAi resulted in 
a slight but significant decrease, suggesting that HPX-2 might be present in the hypodermis and 
contribute to pathogen resistance in this tissue (Figure 4.2 A and B).  
To directly visualize the expression of HPX-2, I created a partial translational fusion of 
HPX-2 to GFP. Specifically, a 4-kb region containing the upstream sequence and the first two 
exons of the hpx-2 gene was cloned to generate a fusion with GFP (Figure 4.3 A). The construct 
was injected into the worms at a concentration of 50 ng/µl with pRF4 (20 ng/µl) as a co-injection 
marker (133). The resulting extrachromosomal array was then integrated into the chromosome 
by the TMP/UV method (106). I initially looked at the stable transgenic worms at different 
development stages but did not observe GFP expression in the majority. Occasionally (in about 
~1% of the worms), I observed a green fluorescent stripe extending from the distal bulb of the 
pharynx to the anterior of the buccal cavity (Figure 4.3 B). I postulated that the expression level 
might be too low to detect. In fact, expression data from Wormbase and our RNA-seq data (see 
below) indicate that the overall expression level of hpx-2 gene is extremely low at the whole 
worm level but increases significantly upon entry into dauer. When I subsequently analyzed 
dauer animals using confocal microscopy, I observed weak expression of hpx-2::GFP in the 
distal bulb of the pharynx in nearly all the animals (Figure 4.3 C). At higher magnification, the 
localization pattern was most consistent with expression in the gland cells (Figure 4.3 D) (134). 
Again, around 1% of the worms showed the striped expression pattern, resembling the structure 
called the “process” that extends from the dorsal g1 gland cell to the anterior of the buccal cavity 
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(Figure 4.3 E). Interestingly, the process functions in transporting excreted material from the 
gland cell to the pharyngeal lumen (135, 136). Overall, these results indicate that hpx-2 is 
expressed in the epidermis and pharynx. 
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Figure 4.2. HPX-2 functionally localizes to the hypodermis of the worm. (A) Survival of the 
intestinal RNAi strain on E. faecalis following exposure to of hpx-2 or VC control RNAi. (B) 
Survival of the hypodermal RNAi strain on E. faecalis following exposure to hpx-2 or VC control 
RNAi. Representative results from single experiments with an n of approximately 90 worms for 
each condition are shown. Median survival and P-values along with replicates are listed in S8 
Table as experiment No.1.  
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Figure 4.3. hpx-2 is expressed in the pharynx. (A) Illustration of upstream region and the first 
two exons of the hpx-2 gene that are fused to gfp. The expression pattern of hpx-2::gfp under 
the confocal microscope in (D) young-adult worms and (E-G) dauer worms. Red arrow head 
indicates the pharyngeal expression of hpx-2. (F) Higher magnification showing the pharyngeal 
expression pattern of hpx-2::gfp.  
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HPX-2 contributes to cuticle integrity  
A functional role in cuticle biogenesis was demonstrated for some of the previously 
studied heme peroxidases and loss-of-function mutations sometimes caused abnormal cuticle 
morphology. For example, MLT-7, was shown to function in conjunction with BLI-3 to cross-link 
the cuticular collagens during the molting process. Loss of MLT-7 resulted in a blistered 
phenotype due to incomplete cross-linking of these extracellular matrix proteins (29). Another 
immune protective peroxidase previously studied by our lab, SKPO-1, has an incomplete 
penetrance of dumpy phenotype when mutated, again suggesting a role in cuticle generation 
(102).  
Given the pathogen sensitivity phenotype that resulted from hypodermal-specific RNAi 
(Figure 4.2 B), I postulated that HPX-2 might play a role in the generation and/or structural 
integrity of the cuticle. However, unlike the mlt-7 or skpo-1 mutants, the hpx-2 animals displayed 
normal morphology as observed under the dissecting microscope (Figure 3.10). To test for more 
subtle defects, cuticle integrity was measured by testing how permeable the animals were to a 
DNA dye (137). Specifically, I exposed the worms to the DNA staining agent Hoechst 33258 
and scored how many exhibited nuclear staining of their hypodermal cells, evidence of dye 
penetration (Figure 4.4 A). While about 15% of N2 animals showed evidence of nuclear 
staining, 25-30% of the HPX-2 mutants displayed this phenotype, indicative of some loss of 
cuticle integrity (Figure 4.4 B).  
Even though the loss of HPX-2 did not affect the low-resolution morphology of the worm, 
I observed that some of the strains generated by injection of higher amounts of the hpx-2 
complementation construct displayed a slightly dumpy or partial roller phenotype. These 
animals were also more sensitive to E. faecalis than wild-type or hpx-2 mutant animals (Figure 
4.5 A and B). I hypothesized that overexpression of hpx-2 might be contributing to these 
phenotypes. The level of hpx-2 expression in the different strain backgrounds was measured, 
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showing a correlation between higher mRNA levels and hyper-sensitivity to E. faecalis (Figure 
4.4 C). The results indicate that too much as well as too little HPX-2 cause cuticle defects and 
sensitivity to the pathogen.  
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Figure 4.4. The cuticle defect of hpx-2 mutants. (A) Hoechst staining of N2, hpx-2(dg047) 
and hpx-2(gk252521) worms. Worms with stained nuclei were scored as positive. Images 
presented are representative of ~300 worms observed. (B) Quantification of Hoechst positive 
worms in N2, hpx-2(dg047) and hpx-2(gk252521) worms. Compared with N2, both mutants had 
significant higher level of Hoechst staining (Phpx-2(dg047)=0.0022, Phpx-2(gk252521)=0.033). The graph 
was generated from 3 independent experiments (n=30). Error bars represent SEM.  
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Figure 4.5. Overexpression of HPX-2 results in susceptibility to E. faecalis. (A) Survival of 
N2, hpx-2(dg047), and the strain overexpressing hpx-2 in hpx-2(dg047) background on E. 
faecalis OG1RF. (B) Survival of N2, hpx-2(gk252521), and the strain overexpressing hpx-2 in 
hpx-2(gk252521) background on E. faecalis OG1RF. (C) qRT PCR showing the relative log2 
(fold change) of hpx-2 gene expression level in hpx-2(dg047) overexpression (OE) and hpx-2 
(gk252521) OE strains compared to N2. The average gene expression of biological triplicates is 
shown, and the error bars represent SEM.  
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HPX-2 limits colonization by E. faecalis, but has no effect on P. aeruginosa 
I next examined the functional relevance of the pharyngeal presence of HPX-2, 
predicting it might contribute to this organ’s structural integrity. The apical surface of the 
pharyngeal lumen is lined with cuticle, which connects to the cuticle of the epidermis. 
Specialized projections of the pharyngeal cuticle can form structures, such as the teeth-like 
formations found in the terminal bulb (grinder) that are thought to contribute to mechanical 
microbial disruption (135). HPX-2 was found to be expressed in the gland cells of the pharynx 
(Figure 4.3 B-E), and one hypothesis for its function is aiding cuticle development/remodeling of 
this organ following excretion into the pharyngeal lumen. I hypothesized that loss of hpx-2 might 
weaken the pharynx, resulting in less disruption of ingested bacteria and increased intestinal 
colonization by pathogens. To test this hypothesis, I exposed L4 worms to a strain of E. faecalis 
OG1RF that constitutively expresses GFP and measured the level of intestinal colonization by 
both fluorescence microscopy and CFU plating (115). At Day 2 of infection, I observed a higher 
level of intestinal colonization in the hpx-2 mutant strains, indicated by higher fluorescent 
intensity and CFU counts (Figure 4.6 A and B). In contrast, when I exposed worms to a P. 
aeruginosa PA14 strain expressing dsRed (117), I did not observe any significant differences 
between the N2 strain and the mutants in either fluorescent intensity or CFUs (Figure 4.6 C and 
D), which is consistent with the observation that N2 and hpx-2 mutants are equally susceptible 
to P. aeruginosa (Figure 3.12 D). Although the hpx-2 mutant might have impaired grinding 
capability, no obvious structural abnormalities of the pharynx were observed when examined by 
light microscopy (Figure 4.7 A). In addition, the pumping rate of the worms was not significantly 
affected (Figure 4.7 B). Together, these results suggest that HPX-2 functions in the pharynx to 
reduce intestinal colonization by some pathogens, possibility through the structural 
reinforcement of the grinder or other parts of the pharyngeal cuticle.  
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Figure 4.6. Intestinal colonization of hpx-2 mutants by pathogens. Colonization of (A) GFP-
labeled E. faecalis OG1RF and (C) dsRed labeled P. aeruginosa PA14 in N2, hpx-2(dg047) and 
hpx-2(gk252521) worms at day two and day one of infection, respectively. (B) E. faecalis CFU 
counts per worm (Phpx-2(dg047) = 0.0471, Phpx-2(gk252521) =0.0275, n=19 (combined from 3 
independent experiments)). (D) E. faecalis CFU counts per worm (Phpx-2(dg047) =0.1833, Phpx-
2(gk252521) =0.2724, n =19 (combined from 3 independent experiments)). Error bars represent 
SEM.  
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Figure 4.7. hpx-2 mutants exhibit normal pharyngeal traits. (A) hpx-2 mutants have normal 
pharynx structure compared to N2 worms. Images are representative of >100 N2, hpx-2(dg047), 
hpx-2(gk252521) worms observed, respectively (C) hpx-2 mutants have comparable pumping 
rates compared to N2 worms. Phpx-2(dg047) =0.071, Phpx-2(gk252521) =0.1147, n =15  
 
N2
P1
CR
SP
R
P1
BC
11
0
100
200
300
Data 1
N2
P1
-C
RI
SP
R
0
100
200
300
400
Data 2
N2
P1-CRISPR
A
Figure S3  
N2 dg047 gk252521
n.s.
Br
oo
d 
siz
e
N2
hpx
-2(d
g04
7)
B
Ph
ar
yn
x p
um
pi
ng
 ra
te
 (m
in
-1
)
A
D
200µm
50µm
N2 dg047 gk252521
n.s. n.s.
N2
hpx
-2(d
g04
7)
hpx
-2(g
k25
252
1)
 69 
The catalytic activity of HPX-2 is required for resistance to pathogens  
Sequence comparison of HPX-2 to other peroxidases indicates that HPX-2 possesses 
all the conserved residues required for peroxidase catalytic activity, including the distal histidine 
(H240 ), the catalytic arginine (R372), and the proximal histidine (H240 ) (reviewed by (138)). On the 
other hand, similar to BLI-3 and MLT-7, HPX-2 lacks the covalent heme-binding residues that 
are conserved in mammalian peroxidases (138). However, this does not rule out the possibility 
of non-covalent heme binding since both human DUOX1 and DUOX2 lack the conserved 
residues but still bind heme weakly (139, 140). Thus, I hypothesize HPX-2 has peroxidase 
activity. 
To test this hypothesis, I used an Amplex red assay that measures pathogen-stimulated 
H2O2 release in the hpx-2 mutant strain hpx-2(dg047) (99) (98). In previous work, a skpo-1 
mutant was characterized as releasing more H2O2 than N2 when exposed to the pathogen E. 
faecalis, presumably because less H2O2 was being consumed (102). In contrast, I found H2O2 
levels generated by the hpx-2(dg047) mutant were comparable to N2 following exposure to E. 
faecalis (Figure 4.8). While this could be because HPX-2 possesses little peroxidase activity, it 
also could be due to its low expression level or a lack of activity under these conditions.  
To directly test the activity of HPX-2 using in vitro assays, I attempted to express the 
HPX-2 recombinant protein in E. coli expression system. Specifically, the cDNA of hpx-2 
encoding full-length protein excluding the signal peptide of HPX-2 was cloned into expression 
vector pET-29b (+) and transformed into in E. coli BL21 (DE3). Unfortunately, upon induction, I 
could not detect any expression of the recombinant protein through SDS-PAGE and Coomassie 
staining. Although a weak band can be detected by Western blotting using anti-His antibody, the 
amount was too little to be used in any biochemical assays.  
To further examine the possible contribution of HPX-2’s peroxidase activity to pathogen 
resistance, I analyzed a strain harboring a single amino acid mutation that changes an active 
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site residue of the peroxidase domain. Specifically, the catalytic arginine residue was 
substituted to alanine through CRISPR-Cas9 mediated mutagenesis (Figure 4.9 A). The 
catalytic arginine is conserved throughout peroxidase–cyclooxygenase superfamily, and the 
substitution of the arginine to alanine abolishes peroxidase activity (141, 142).  Like the hpx-2 
deletion mutants, this point mutant exhibited increased sensitivity to E. faecalis, suggesting that 
the catalytic activity of the peroxidase active site of HPX-2 is required for the pathogen 
resistance phenotype (Figure 4.9 B).  
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Figure 4.8 Amplex red assay of N2 and hpx-2(dg047) mutant. Worms were grown to L4 
stage and exposed to E. coli OP50 or E. faecalis OG1RF for 16 hours at 25°C. The amount of 
H2O2 was then measured with or without exposure to 80mM diphenyleneiodinium chloride (DPI). 
Error bars represent the SEM and P values were calculated via Student’s paired t-test. Data is 
representative of three independent replicates.  
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Figure 4.9. HPX-2 peroxidase activity is required for pathogen resistance. (A) Sequence 
alignment of the peroxidase domain of HPX-2 and HPX-2 site-directed (SD) mutant to other 
peroxidases and DUOX. hMPO, human myeloperoxidase. (B) The survival of N2 and HPX-2-SD 
strain (hpx-2 (syb238)) on E. faecalis. Results from one representative experiment with an n of 
approximately 90 worms for each condition are shown. Median survival and P-values are listed 
in Table 4.1 as experiment No.1 along with other biological replicates. 
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Figure 
number 
Experiment 
number  
Strain Exposure 
conditions  
Median 
survival 
(days) 
P-value  
3A 1 vha-2 VC RNAi E. faecalis 5 C 
  vha-2 hpx-2 RNAi E. faecalis 5 0.8339 
 2 vha-2 VC RNAi E. faecalis 5 C 
  vha-2 hpx-2 RNAi E. faecalis 3 0.9548 
3B 1 wrt-2 VC RNAi E. faecalis 5 C 
  wrt-2 hpx-2 RNAi E. faecalis 5 0.0022 
 2 wrt-2 VC RNAi E. faecalis 5 C 
  wrt-2 hpx-2 RNAi E. faecalis 3 0.0029 
 3 wrt-2 VC RNAi E. faecalis 5 C 
  wrt-2 hpx-2 RNAi E. faecalis 4 0.0005 
4.8 B 1 N2 E. faecalis 6 C 
  hpx-2(syb482) E. faecalis 6 0.0005 
 2 N2 E. faecalis 4 C 
  hpx-2(syb482) E. faecalis 4 0.0145 
Table 4.1 Median survival and P-values in killing assays 
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Discussion 
In this chapter, I demonstrated that HPX-2 is produced in the pharynx and hypodermis of 
the worms, as well as its function in cuticle strengthening and pathogen resistance.  
Pharyngeal function of HPX-2 
In the pharynx, the expression pattern of hpx-2::GFP resembles that of the gland cell 
reporter gene B02807::GFP (143, 144), with expression being observed in the process that 
extends from the terminal bulb to the posterior end of the buccal cavity. There are two groups of 
gland cells, three g1 cells and two g2 cells, located at the distal bulb of the pharynx. The gland 
cells are thought to secrete vesicles containing enzymes that function in the digestion of 
microbial food and aid in cuticle formation during the molting process (136). Specifically, during 
the feeding process, small vesicles are transported from the g1 cells through the process to the 
secretory ducts to aid digestion. During molting, much larger vesicles are transported through 
the process and the enzymes they contain are thought to be involved in the tearing down and 
building up of the cuticle, a critical remodeling process (136). 
I postulate that HPX-2 is protective by virtue of it being secreted into the pharyngeal 
lumen by gland cells to aid in cuticle remodeling of the pharynx during development. A properly 
developed pharyngeal cuticle is likely necessary for effective disruption of microbes during the 
digestive process. Because Gram-positive bacteria and fungi like C. albicans have thicker, 
harder-to-disrupt cell walls, this model could explain why the hpx-2 mutants were colonized 
more efficiently by, and were more susceptible to, these pathogens compared to Gram-negative 
bacteria (Figures 3.12). The cell envelope of Gram-negatives is comprised of two membranes, 
but only a thin layer of peptidoglycan, rendering these organisms easier to disrupt by 
mechanical means (Reviewed in (145)), and may explain why the hpx-2 mutants were not more 
susceptible to them.  
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In previous studies examining staged animals, significant levels of hpx-2 expression 
were only observed during dauer (146). Using lines expressing an HPX-2::GFP fusion, I also 
detected expression during dauer in most animals examined (Figure 4.3). However, I did not 
observe GFP expression in the vast majority of animals at other stages (L1-L4 and adult) and 
during pathogen exposure. Using the HPX-2::GFP line, I occasionally saw expression in the 
pharynx of animals examined at the L4 to young adult stages and speculate that they might be 
animals undergoing molting. Based on all these observations, I speculate that hpx-2 is 
expressed during times of cuticle remodeling, including the larval molts and dauer formation. 
Additionally, HPX-2 may be subject to mechanisms of post-transcriptional regulation that would 
not necessarily be elucidated by these approaches focused on transcriptional regulation. 
Hypodermal function of HPX-2 
Peroxidases play important roles in cuticle bio-generation process and loss-of-function 
mutants frequently exhibit morphological defects. Mutations in MLT-7 or the peroxidase domain 
of BLI-3 result in severe blister phenotypes (29, 147). skpo-1 mutants have a partially penetrant 
dumpy phenotype (102). Loss of HPX-2 did not result in a morphological phenotype observable 
by light-microscopy. However, the increase in cuticle permeability, as evidenced by Hoechst 
staining, indicates some perturbation of the cuticle. Additionally, overexpression of hpx-2, by 
injection of higher concentrations of the transgene, resulted in some dpy and rol animals, again 
indicative of HPX-2 playing a role cuticle biogenesis. Tissue-specific RNAi knock-down of hpx-2 
in the hypodermis resulted in a weak susceptibility phenotype. Collectively, these data suggest 
that hpx-2 is expressed and plays an infection-protective role in the hypodermis, though 
expression of our HPX-2::GFP transgene was not detectable in this tissue.  
 How might a cuticle impaired by lack of HPX-2 translate into susceptibility to pathogen? 
First of all, it is important to note that not all cuticle defects alter sensitivity. For example, mlt-7 
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mutations and bli-3 peroxidase domain mutations result in severe blistered phenotypes, with no 
concomitant increase in pathogen susceptibility (99, 102) Interestingly, a recent study showed 
that disruption of some, but not all, aspects of cuticle structure triggers the activation of multiple 
stress response pathways (148). Specifically, it was discovered that disruption of the annular 
furrows activates detoxification, osmolyte, and most importantly, antimicrobial responses. In 
regard to HPX-2, I hypothesize that structural disturbance of the hypodermal cuticle perturbs 
signal transduction related to innate immune and/or stress responses. However, a precise 
understanding will require more detailed knowledge of exactly how HPX-2 modulates cuticle 
structure. 
In conclusion, I report the characterization of a peroxidase, HPX-2, that functions 
protectively against multiple pathogen infections in C. elegans. The data suggest that HPX-2 
contributes in a peroxidase-dependent manner either directly, by modulating the cuticular 
structure, and/or indirectly, by affecting downstream innate immune and/or stress responses 
pathways. While further investigations will be required to elucidate the precise mechanism, our 
findings highlight the complexity and multiple factors involved in pathogen defense.  
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Chapter 5 Transcriptome analysis reveals that hpx-2 mutant misregulates genes for 
cuticle synthesis and has a stronger response to infection. 
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Introduction 
In the last two chapters, I demonstrated that HPX-2 is expressed in the pharynx and 
hypodermis of the worm and functions in pathogen resistance. More specifically, it reduced 
intestinal colonization of Gram-positive bacteria. I also showed that over-expression of HPX-2 
not only resulted in pathogen susceptibility comparable to hpx-2 mutants, but also caused 
abnormal body morphology, i.e. occasional dumpy and roller phenotypes. These findings 
strongly suggest that HPX-2 plays roles in pathogen resistance and cuticle biogenesis. 
However, the exact mechanisms and the pathways by which HPX-2 operates in these two 
processes are not clear. Furthermore, the loss of HPX-2 did not result in any physiological 
changes in the animal under non-pathogenic conditions, making it hard to pin-point the functions 
of HPX-2 during normal development of the worms. Thus, I decided to utilize RNAseq analysis 
as an un-biased and highly sensitive method to measure the changes in gene expression 
profile, which reflects the overall physiology of the animal. I also decided to examine hpx-2 
animals exposed to the pathogen E. faecalis to determine if the innate immune response was 
significantly different than that of the N2 reference strain.  I believe that investigating the global 
transcriptional changes in both the hpx-2 mutant and the N2 wild-type, under non-pathogenic 
and pathogenic conditions might uncover some insights into the mechanisms and pathways by 
which HPX-2 influences pathogen susceptibility and cuticle development.  
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Results 
Transcriptome analysis reveals that hpx-2 mutant misregulates genes for cuticle 
syntheses.  
To better understand how the loss of HPX-2 affected the global gene profile of the worm, 
I examined the differences in gene expression of a hpx-2 mutant (hpx-2(dg047)) compared to 
the N2 reference strain under both non-pathogenic (exposed to E. coli OP50) and pathogenic 
(exposed to E. faecalis OG1RF) conditions.  
First, under the non-pathogenic condition (exposed to E. coli OP50), there were a total of 
69 genes that were significantly differentially expressed in the mutant, with 34 genes up-
regulated and 35 down-regulated. 21 of the affected genes encode structural constituents of the 
cuticle, including 17 col genes, 3 dpy genes (dpy-3, dpy-4, and dpy-5), and 2 rol genes (rol-1 
and rol-6). GO term analysis further revealed an enrichment of genes that are involved.  All of 
them are downregulated, suggesting a perturbed cuticle biogeneration process upon the loss of 
HPX-2 (Table 5.1). In addition, genes involved in locomotion are also affected, which could 
explain the partial roller and dumpy phenotype in the HPX-2 overexpression strains examined in 
chapter 4 (Table 5.1). 
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hpx-2(dg047) on OP50 vs. N2 on OP50  
Category Term Count Fold 
Enrichment 
P-value  
BP body morphogenesis 32 6.6 8.30E-18 
BP locomotion 39 3.5 5.30E-13 
BP collagen and cuticulin-based cuticle 
development 11 12.4 1.50E-08 
BP molting cycle, collagen and cuticulin-based 
cuticle 14 6 4.80E-07 
BP cellular response to osmotic stress 5 42.6 4.30E-06 
BP UV protection 5 39.9 5.70E-06 
BP single-organism transport 4 73 1.50E-05 
BP molting cycle process 4 30.1 2.80E-04 
BP cuticle development 4 26.9 4.00E-04 
BP epithelial cell development 4 21.3 8.10E-04 
BP intein-mediated protein splicing 3 42.6 2.10E-03 
BP cuticle development involved in collagen and 
cuticulin-based cuticle molting cycle 3 42.6 2.10E-03 
BP response to osmotic stress 3 38.3 2.60E-03 
BP response to oxidative stress 5 8.5 2.70E-03 
BP cell-cell signaling 3 34.8 3.10E-03 
BP nematode larval development 27 1.7 3.80E-03 
BP MAPK cascade 3 16.7 1.30E-02 
BP defense response 5 5.3 1.40E-02 
BP regulation of multicellular organism growth 3 13.7 2.00E-02 
BP nematode male tail tip morphogenesis 4 6.6 2.20E-02 
BP segment polarity determination 2 63.9 3.10E-02 
BP protein catabolic process 5 4.1 3.30E-02 
CC collagen trimer 35 26 5.50E-40 
CC cell periphery 6 32.3 8.80E-07 
CC collagen and cuticulin-based cuticle 
extracellular matrix 5 58.7 1.00E-06 
CC extracellular region 10 3.9 9.40E-04 
MF structural constituent of cuticle 41 30 2.30E-51 
MF structural constituent of collagen and 
cuticulin-based cuticle 7 39.2 1.50E-08 
MF MAP kinase activity 3 28.4 4.70E-03 
MF hydrolase activity, acting on carbon-nitrogen 
(but not peptide) bonds 2 18.9 9.90E-02 
Table 5.1: GO Term analysis of genes that changed upon loss of HPX-2 (hpx-2(dg047)) 
compared to N2, when exposed to E. coli OP50. Genes that are involved in cuticle 
generation and body morphogenesis are enriched in the hpx-2 mutant. BP: Biological 
Processes; MF: Molecular Functions. CC: Cellular Component. 
 81 
I next analyzed gene expression changes in a hpx-2 mutant after 16 hours of exposure 
to E. faecalis OG1RF compared to N2 strain.  I chose this early time point because the worms 
show limited damage and thus the indirect effects should be smaller than later during infection. 
Under these conditions, there were a total of 125 genes that were differentially expressed in the 
mutant (72 up-regulated and 53 down-regulated) with 106 of them unique to the pathogenic 
condition. Interestingly, genes involved in cuticle generation were again significantly altered, and 
with a greater enrichment score (Table 5.2). Compared to the 21 genes under nonpathogenic 
conditions, a total of 41 cuticle genes were affected and up-regulated. In addition to the 
increased changes in cuticle structural genes, there was an enrichment of genes encoding 
proteins involved in defense response to Gram-positive bacteria (Table 5.2). These include 4 
out of 10 lysozyme genes (lys-1, lys-2, lys-3, and lys-7), and f53a9.8, which is involved in 
defense response against Gram-positive bacteria and expressed in the intestine (144, 149, 
150).  Additionally, genes that are involved in general innate immune response, response to 
Gram-negative, and xenobiotic stress response were also enriched, although there was some 
overlap of genes in those groups (Table 5.2).  
In order to verify the RNAseq result, I performed qRT-PCR on 10 genes that are 
changed in expression in the hpx-2 mutant compared to N2 under the pathogenic condition. The 
log2 change in gene expression from qRT data was then plotted against the RNAseq data to 
evaluate their correlation (Figure 5.1).  Trend line analysis revealed that R2 > 0.9, suggesting 
consistency between the RNAseq data and the qRT-PCR data.  
Finally, in order to compare the genes that were differentially expressed under the non-
pathogenic compared to the pathogenic condition, I plotted the gene lists against each other 
(Figure 5.2). In general, there was a close correlation between the two conditions, meaning 
genes that were differentially expressed under one condition were also changed in the other, 
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although the degree of changes was sometimes different. In addition, the degree of fold-change 
was quite small with majority of the log2 changes less than 2 (Figure 5.2).  
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hpx-2(dg047) on OG1RF vs. N2 on OG1RF  
Category Term Count Fold 
Enrichment 
P-value  
BP innate immune response 21 5.7 4.80E-10 
BP metabolic process 32 2.6 8.00E-07 
BP response to xenobiotic stimulus 5 54.2 1.10E-06 
BP defense response to Gram-negative 
bacterium 9 9.3 5.00E-06 
BP defense response 10 7.2 9.80E-06 
BP defense response to Gram-positive bacterium 6 13 8.70E-05 
BP response to nematicide 4 31.6 2.30E-04 
BP flavonoid glucuronidation 6 7.3 1.30E-03 
BP flavonoid biosynthetic process 6 7.3 1.30E-03 
BP MAPK cascade 4 15.1 2.20E-03 
BP response to osmotic stress 3 26 5.50E-03 
BP transmembrane transport 11 2.3 2.00E-02 
BP proteolysis involved in cellular protein 
catabolic process 4 6 2.90E-02 
BP oxidation-reduction process 11 1.8 7.60E-02 
BP monocarboxylic acid transport 2 21.7 8.80E-02 
BP response to gamma radiation 2 19.3 9.80E-02 
CC intracellular membrane-bounded organelle 7 6.1 9.40E-04 
CC extracellular region 11 3.4 1.50E-03 
CC lysosome 5 6.9 5.90E-03 
CC collagen trimer 7 4.1 7.10E-03 
CC membrane raft 4 5.6 3.30E-02 
MF ATPase activity, coupled to transmembrane 
movement of substances 7 7 6.00E-05 
MF iron ion binding 8 8 6.50E-04 
MF steroid hydroxylase activity 5 5 1.30E-03 
MF carbohydrate binding 12 12 1.50E-03 
MF ATPase activity 7 7 1.70E-03 
MF efflux transmembrane transporter activity 3 3 2.30E-03 
MF heme binding 8 8 3.50E-03 
MF transferase activity, transferring hexosyl 
groups 6 6 4.10E-03 
MF oxidoreductase activity, acting on paired 
donors, with incorporation or reduction of 
molecular oxygen 6 6 4.50E-03 
MF structural constituent of cuticle 8 8 5.60E-03 
MF monooxygenase activity 6 6 7.30E-03 
MF glucuronosyltransferase activity 5 5 9.90E-03 
MF MAP kinase activity 3 3 1.10E-02 
MF ATP binding 20 20 3.20E-02 
MF oxidoreductase activity 11 11 4.30E-02 
MF nutrient reservoir activity 2 2 7.40E-02 
MF protein serine/threonine kinase activity 8 8 7.90E-02 
MF cysteine-type endopeptidase activity 3 3 9.20E-02 
 84 
MF monocarboxylic acid transmembrane 
transporter activity 2 2 9.80E-02 
 
Table 5.2: GO Term analysis of genes that changed upon loss of HPX-2 (hpx-2(dg047)) 
compared to N2, when exposed to E. faecalis OG1RF.Genes that are involved in cuticle 
generation and body morphogenesis are further enriched in the hpx-2 mutant. Additionally, 
defense response genes are enriched as well. BP: Biological Processes; MF: Molecular 
Functions. CC: Cellular Component. 
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Figure 5.1 qRT-PCR validation of 10 selected genes differentially expressed in the RNA-
seq analysis of hpx-2(dg047) to N2 on E. faecalis. Mean log2 (fold change) determined in 
three independent qRT-PCR were plotted against the log2 (fold change) from the RNAseq 
experiments. 
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Figure 5.2. Scatter plot of genes changed in hpx-2(dg047) animals, as compared to N2 
animals, when either exposed to E. coli (x-axis) or E. faecalis (y-axis). Values of 10 or -10 
indicate expression level under one condition was 0 RPKM.  
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Transcriptome analysis reveals a stronger response in hpx-2 mutant upon infection.  
To understand the general response of the worms when exposed to E. faecalis, I 
examined the gene profiles of animals exposed to E. faecalis as compared to those exposed to 
OP50. Not surprisingly, there were a great number of genes that were differentially expressed 
when exposed to pathogen, suggesting a global reaction that involves in host defense.  In N2, a 
total of 4217 genes (2560 up-regulated and 1657 down-regulated) were significantly 
differentially expressed, many of which were consistent with previously published data (79). GO 
term analysis revealed a long list of genes that are involved in multiple physiological process, 
with innate immune response being the most significant one (Table 5.3).  In the hpx-2 mutant, 
however, an even larger number of genes were significantly differentially expressed: 8313 
genes in total with 4255 of them up-regulated and 4058 down-regulated (Table 5.4). To examine 
the relationship between the two sets of genes, genes that were significantly expressed under at 
least one condition were plotted (Figure 5.3). Compared to the N2 strain, the hpx-2 mutant had 
similar, but stronger responses to the pathogen, contributing to the larger number of genes with 
significant changes in expression under the pathogenic condition. In summary, we conclude that 
the loss of hpx-2 results in a stronger response to infection, perhaps reflecting the increased 
microbial load experienced by this strain during E. faecalis infection (Figure 4.6 A and B). 
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N2 on OP50 vs. N2 on OG1RF 
Category Term Count Fold 
Enrichment 
P-value  
BP innate immune response 70 3.3 3.30E-19 
BP oxidation-reduction process 74 2.1 7.40E-10 
BP metabolic process 120 1.7 4.90E-09 
BP flavonoid glucuronidation 21 4.4 2.00E-08 
BP flavonoid biosynthetic process 21 4.4 2.00E-08 
BP cell projection organization 10 8.3 6.80E-07 
BP nonmotile primary cilium assembly 11 5 3.60E-05 
BP defense response to Gram-negative 
bacterium 17 3 1.10E-04 
BP cilium assembly 10 4.8 1.30E-04 
BP dauer entry 12 3.7 3.00E-04 
BP steroid hormone mediated signaling pathway 35 1.9 5.00E-04 
BP single-organism transport 5 10.7 5.80E-04 
BP fatty acid metabolic process 11 3.5 8.70E-04 
BP defense response to Gram-positive bacterium 10 3.8 1.00E-03 
BP response to xenobiotic stimulus 5 9.4 1.10E-03 
BP lipid metabolic process 26 1.9 3.50E-03 
BP epithelial cell development 7 4.4 4.00E-03 
BP defense response 17 2.1 6.30E-03 
BP transcription, DNA-templated 54 1.4 9.80E-03 
BP transmembrane transport 41 1.5 1.10E-02 
BP fatty acid beta-oxidation 6 4.3 1.10E-02 
BP positive regulation of transcription from RNA 
polymerase II promoter 20 1.9 1.10E-02 
BP homophilic cell adhesion via plasma 
membrane adhesion molecules 5 5.4 1.10E-02 
BP cell-matrix adhesion 4 7.5 1.30E-02 
BP regulation of transcription, DNA-templated 67 1.3 1.40E-02 
BP negative regulation of transcription from RNA 
polymerase II promoter 13 2.2 1.40E-02 
BP carbohydrate metabolic process 19 1.8 1.60E-02 
BP collagen and cuticulin-based cuticle 
development 15 2 1.70E-02 
BP neuron differentiation 5 4.7 1.90E-02 
BP molting cycle process 5 4.4 2.30E-02 
BP regulation of neuron differentiation 4 5.5 3.20E-02 
BP response to nematicide 4 5.5 3.20E-02 
BP cuticle development 5 4 3.40E-02 
BP vulval location 5 4 3.40E-02 
BP heme transport 3 9 3.90E-02 
BP interneuron axon guidance 3 9 3.90E-02 
BP nervous system development 11 2.1 3.90E-02 
BP one-carbon metabolic process 4 4.6 5.10E-02 
BP intraciliary transport 4 4.6 5.10E-02 
BP sphingolipid metabolic process 6 2.9 5.20E-02 
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BP anion transport 9 2.2 5.20E-02 
BP macromolecule glycosylation 5 3.4 5.40E-02 
BP MAPK cascade 5 3.3 6.30E-02 
BP lipid storage 56 1.2 6.80E-02 
BP dephosphorylation 8 2.2 7.10E-02 
BP fatty acid beta-oxidation using acyl-CoA 
dehydrogenase 5 3.1 7.10E-02 
BP cell wall macromolecule catabolic process 3 6.4 7.40E-02 
BP proteolysis involved in cellular protein 
catabolic process 8 2.1 8.90E-02 
BP protein localization to ciliary transition zone 3 5.6 9.50E-02 
BP unsaturated fatty acid biosynthetic process 3 5.6 9.50E-02 
BP intraciliary retrograde transport 3 5.6 9.50E-02 
BP regulation of backward locomotion 3 5.6 9.50E-02 
CC collagen trimer 40 3.6 3.40E-12 
CC intracellular membrane-bounded organelle 27 3.6 1.40E-08 
CC extracellular region 49 2.3 7.70E-08 
CC membrane raft 20 4.3 8.10E-08 
CC ciliary basal body 9 6.7 2.70E-05 
CC extracellular space 35 2.1 4.80E-05 
CC BBSome 5 11.1 5.00E-04 
CC cilium 10 3.2 3.10E-03 
CC lysosome 12 2.5 7.20E-03 
CC cell projection 13 2 3.00E-02 
CC gut granule membrane 3 9.3 3.60E-02 
CC intraciliary transport particle B 4 5.2 3.70E-02 
CC apical plasma membrane 9 2.2 4.70E-02 
CC proteinaceous extracellular matrix 6 2.9 5.10E-02 
CC nonmotile primary cilium 9 2 8.40E-02 
CC peroxisome 6 2.5 9.40E-02 
MF structural constituent of cuticle 40 3.3 2.40E-11 
MF monooxygenase activity 28 4.1 2.30E-10 
MF iron ion binding 31 3.8 2.40E-10 
MF oxidoreductase activity, acting on paired 
donors, with incorporation or reduction of 
molecular oxygen 26 4.3 4.90E-10 
MF oxidoreductase activity 63 2.1 2.50E-08 
MF heme binding 33 3 2.70E-08 
MF transferase activity, transferring hexosyl 
groups 23 3.9 4.50E-08 
MF steroid hydroxylase activity 14 5.2 1.10E-06 
MF glucuronosyltransferase activity 18 3.8 2.40E-06 
MF sequence-specific DNA binding 57 1.7 4.40E-05 
MF cholinesterase activity 11 4.5 8.60E-05 
MF carbohydrate binding 38 1.8 6.90E-04 
MF transcription factor activity, sequence-specific 
DNA binding 55 1.6 9.30E-04 
MF RNA polymerase II regulatory region 
sequence-specific DNA binding 16 2.4 2.00E-03 
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MF transmembrane transporter activity 18 2.3 2.30E-03 
MF lysozyme activity 5 7 3.80E-03 
MF UDP-glycosyltransferase activity 7 4.3 4.50E-03 
MF metal ion binding 132 1.2 4.80E-03 
MF efflux transmembrane transporter activity 4 9.3 6.10E-03 
MF hydrolase activity, acting on ester bonds 8 3.1 1.20E-02 
MF transferase activity, transferring glycosyl 
groups 20 1.8 1.60E-02 
MF RNA polymerase II transcription factor 
activity, sequence-specific DNA binding 10 2.4 2.10E-02 
MF carboxylic ester hydrolase activity 6 3.7 2.10E-02 
MF ATPase activity, coupled to transmembrane 
movement of substances 9 2.3 3.60E-02 
MF transcriptional activator activity, RNA 
polymerase II core promoter proximal region 
sequence-specific binding 4 5.1 3.90E-02 
MF heme transporter activity 3 8.4 4.40E-02 
MF ATPase activity 13 1.8 5.10E-02 
MF MAP kinase activity 4 4.3 6.00E-02 
MF stearoyl-CoA 9-desaturase activity 3 7 6.30E-02 
MF acid phosphatase activity 6 2.7 6.60E-02 
MF acyl-CoA dehydrogenase activity 5 3 7.70E-02 
MF acyl-CoA oxidase activity 3 6 8.40E-02 
MF oxidoreductase activity, acting on the CH-CH 
group of donors, with a flavin as acceptor 5 2.9 8.70E-02 
MF DNA binding 68 1.2 9.30E-02 
 
Table 5.3: GO Term analysis of genes that changed in N2 strain under pathogenic 
conditions (exposed to E. faecalis OG1RF) compared to non-pathogenic conditions 
(exposed to E. coli OP50). BP: Biological Processes; MF: Molecular Functions. CC: Cellular 
Component. 
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hpx-2(dg047) on OP50 vs. hpx-2(dg047) on OG1RF 
Category Term Count Fold 
Enrichment 
P-value  
BP protein dephosphorylation 71 3.3 3.00E-21 
BP peptidyl-tyrosine dephosphorylation 50 3.7 1.70E-17 
BP innate immune response 83 2.2 6.20E-12 
BP regulation of cell shape 39 3.3 1.10E-11 
BP peptidyl-serine phosphorylation 38 2.4 3.90E-07 
BP epithelial cell development 13 4.5 6.00E-06 
BP metabolic process 175 1.4 7.40E-06 
BP nonmotile primary cilium assembly 15 3.8 1.10E-05 
BP protein phosphorylation 83 1.6 1.60E-05 
BP peptidyl-tyrosine autophosphorylation 17 3.3 2.00E-05 
BP molting cycle process 10 4.9 5.10E-05 
BP homophilic cell adhesion via plasma 
membrane adhesion molecules 9 5.3 6.70E-05 
BP cell projection organization 10 4.6 9.10E-05 
BP transmembrane receptor protein tyrosine 
kinase signaling pathway 18 2.8 9.80E-05 
BP cuticle development 10 4.4 1.50E-04 
BP intraciliary transport 8 5.1 3.20E-04 
BP single-organism transport 6 7.1 4.30E-04 
BP oxidation-reduction process 87 1.4 1.40E-03 
BP negative regulation of endopeptidase activity 16 2.4 2.00E-03 
BP cell differentiation 36 1.7 2.20E-03 
BP defense response 27 1.9 2.20E-03 
BP cilium assembly 11 2.9 2.50E-03 
BP flavonoid biosynthetic process 18 2.1 3.80E-03 
BP flavonoid glucuronidation 18 2.1 3.80E-03 
BP nematode male tail tip morphogenesis 19 2 3.90E-03 
BP defense response to Gram-negative 
bacterium 20 2 4.50E-03 
BP detection of stimulus involved in sensory 
perception 4 8.3 6.30E-03 
BP sperm motility 4 8.3 6.30E-03 
BP cell-matrix adhesion 5 5.2 9.80E-03 
BP positive regulation of transcription from RNA 
polymerase II promoter 31 1.6 1.00E-02 
BP hyperosmotic response 8 2.9 1.60E-02 
BP proteolysis 59 1.3 2.00E-02 
BP carbohydrate metabolic process 29 1.5 2.10E-02 
BP chemotaxis 14 2 2.10E-02 
BP mesodermal cell migration 5 4.1 2.40E-02 
BP dorsal/ventral axon guidance 7 2.9 2.60E-02 
BP collagen and cuticulin-based cuticle 
development 22 1.6 2.80E-02 
BP dauer entry 12 2 2.90E-02 
BP regulation of neuron differentiation 5 3.8 3.40E-02 
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BP cell-cell signaling 5 3.8 3.40E-02 
BP fatty acid alpha-oxidation 3 8.3 4.00E-02 
BP defense response to Gram-positive bacterium 10 2.1 4.50E-02 
BP spermatid development 5 3.5 4.70E-02 
BP spermatogenesis 12 1.9 4.80E-02 
BP fatty acid metabolic process 11 1.9 5.00E-02 
BP 3'-UTR-mediated mRNA destabilization 6 2.8 5.60E-02 
BP multicellular organism development 61 1.2 5.70E-02 
BP response to xenobiotic stimulus 4 4.1 6.10E-02 
BP protein localization to ciliary transition zone 4 4.1 6.10E-02 
BP regulation of backward locomotion 4 4.1 6.10E-02 
BP anterior/posterior pattern specification 5 3.2 6.10E-02 
BP chitin metabolic process 5 3.2 6.10E-02 
BP one-carbon metabolic process 5 3.2 6.10E-02 
BP lipid metabolic process 34 1.3 6.90E-02 
BP male meiosis chromosome segregation 3 6.2 7.40E-02 
BP Roundabout signaling pathway 3 6.2 7.40E-02 
BP cell fate specification involved in pattern 
specification 3 6.2 7.40E-02 
BP regulation of axonogenesis 3 6.2 7.40E-02 
BP S-adenosylmethionine biosynthetic process 3 6.2 7.40E-02 
BP response to gamma radiation 4 3.7 8.40E-02 
BP peptidyl-tyrosine phosphorylation 10 1.8 8.50E-02 
BP response to stimulus 5 2.8 9.70E-02 
BP L-amino acid transport 5 2.8 9.70E-02 
BP oxygen transport 6 2.4 9.90E-02 
CC collagen trimer 64 3.1 6.60E-17 
CC extracellular region 84 2.1 2.40E-11 
CC membrane raft 23 2.7 2.30E-05 
CC extrinsic component of cytoplasmic side of 
plasma membrane 17 3.2 2.70E-05 
CC intracellular membrane-bounded organelle 29 2.1 2.10E-04 
CC ciliary basal body 10 4 3.90E-04 
CC cilium 15 2.6 1.10E-03 
CC integral component of membrane 779 1.1 1.30E-03 
CC intraciliary transport particle B 7 4.8 1.50E-03 
CC membrane 788 1.1 1.50E-03 
CC neuron projection 18 2 5.90E-03 
CC axoneme 6 4.5 6.20E-03 
CC proteinaceous extracellular matrix 10 2.6 1.10E-02 
CC cell projection 21 1.7 1.80E-02 
CC nonmotile primary cilium 16 1.9 2.00E-02 
CC axonemal microtubule 3 8.3 4.00E-02 
CC motile cilium 4 4.7 4.20E-02 
CC BBSome 4 4.7 4.20E-02 
CC chromatin 7 2.3 7.10E-02 
CC cytoskeleton 36 1.3 7.30E-02 
CC dendrite 15 1.6 7.40E-02 
CC extracellular space 40 1.3 7.70E-02 
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MF structural constituent of cuticle 67 3.1 1.60E-18 
MF protein tyrosine phosphatase activity 51 3.5 7.20E-17 
MF phosphoprotein phosphatase activity 42 3.1 7.90E-12 
MF receptor binding 27 3.1 8.90E-08 
MF heme binding 43 2.2 8.90E-07 
MF monooxygenase activity 31 2.6 1.20E-06 
MF iron ion binding 34 2.3 3.90E-06 
MF protein kinase activity 84 1.6 7.10E-06 
MF oxidoreductase activity, acting on paired 
donors, with incorporation or reduction of 
molecular oxygen 27 2.5 1.20E-05 
MF non-membrane spanning protein tyrosine 
kinase activity 19 3 1.60E-05 
MF protein tyrosine kinase activity 26 2.5 1.80E-05 
MF hydrolase activity 133 1.3 5.30E-04 
MF steroid hydroxylase activity 14 2.9 5.50E-04 
MF serine-type endopeptidase inhibitor activity 16 2.6 6.30E-04 
MF oxidoreductase activity 75 1.4 2.40E-03 
MF metallopeptidase activity 30 1.8 2.70E-03 
MF transferase activity, transferring hexosyl 
groups 21 2 3.30E-03 
MF protein serine/threonine kinase activity 54 1.5 4.20E-03 
MF Roundabout binding 4 7.8 7.50E-03 
MF transcriptional activator activity, RNA 
polymerase II core promoter proximal region 
sequence-specific binding 6 4.3 8.00E-03 
MF chitin binding 13 2.2 1.30E-02 
MF RNA polymerase II regulatory region 
sequence-specific DNA binding 20 1.7 2.20E-02 
MF metalloendopeptidase activity 23 1.6 2.20E-02 
MF lysozyme activity 5 3.9 2.90E-02 
MF glucuronosyltransferase activity 15 1.8 3.60E-02 
MF transmembrane transporter activity 22 1.5 4.40E-02 
MF phytanoyl-CoA dioxygenase activity 3 7.8 4.50E-02 
MF structural constituent of collagen and 
cuticulin-based cuticle 7 2.5 5.20E-02 
MF transporter activity 21 1.5 5.80E-02 
MF calcium ion binding 34 1.4 6.00E-02 
MF UDP-glycosyltransferase activity 7 2.4 6.30E-02 
MF oxidoreductase activity, acting on single 
donors with incorporation of molecular 
oxygen, incorporation of two atoms of oxygen 4 3.9 7.10E-02 
MF ATPase activity, coupled to transmembrane 
movement of substances 12 1.7 7.60E-02 
MF methionine adenosyltransferase activity 3 5.9 8.20E-02 
MF acid phosphatase activity 8 2 9.10E-02 
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Table 5.3: GO Term analysis of genes that changed in hpx-2 mutant strain under 
pathogenic conditions (exposed to E. faecalis OG1RF) compared to non-pathogenic 
conditions (exposed to E. coli OP50). BP: Biological Processes; MF: Molecular Functions. 
CC: Cellular Component. 
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Figure 5.3. Scatter plot of genes changed under pathogenic conditions, as compared to 
non-pathogenic conditions, in either N2 strain (x-axis) or hpx-2 mutant (y-axis). Values of 
10 or -10 indicate expression level under one condition was 0 RPKM.  
 
 
 
 
Figure 7 
GO Term analysis of genes that changed upon loss of hpx-2 compared to N2, 
on E. faecalis
GO Term BP Enrichment 
score
Gene
Structural constituent of collagen and 
cuticulin-based cuticle 
5.4 bli-6, sqt-3, dpy-13, dpy-5, rol-6, 
sqt-1, rol-1
Cellular response to osmotic stress 2.06 dpy-5, sqt-1, col-145
UV protection 2.06 dpy-5, sqt-1, col-145
Defense response to Gram-positive 
bacterium
1.73 lys-1, lys-2, lys-7, F53A9.8
proteolysis involved in cellular protein 
catabolic process
0.78 Y16B4A.2, cpr-3, cpr-2
Proteolysis 0.62 asp-13, Y16B4A.2, cpr-3, cpr-2, 
sdc-3, T16G12.1
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Discussion 
In this chapter, RNASeq revealed that loss of hpx-2 modestly impacts the expression of 
genes that are involved in cuticle generation, body morphogenesis, and immune defense 
against pathogenic bacteria, indicating HPX-2 may be influencing these processes. This 
observation is consistent with the weaker cuticle structure and increased susceptibility to 
pathogens (Figure 3.12 and Figure 4.4). 
Although the transcriptome changes detected in the worms were modest, both in the 
number of genes affected and the amplitude of the effect, several observations suggest these 
reflect the biological effect of HPX-2. First, hpx-2 gene expression is restricted to a few cells, 
and thus we would not expect large transcriptome effects that are averaged over the whole 
animal. Second, we performed five biological replicates of RNAseq and the differences were 
highly reproducible. Third, the affected genes are enriched for cuticle biogenesis, which 
correlates well with the known requirement for peroxidases in cuticle cross-linking. Fourth, 
although the overlap in genes that were significantly affected in hpx-2 mutant under the two 
conditions is modest, in most cases genes that were significantly affected in one direction under 
the E. coli condition were affected in the same direction under the E. faecalis condition and vice 
versa, even if the effect reached significance only in one comparison (Figure 5.3). Finally, I used 
qRT-PCR to validate ten genes that were changed in the hpx-2 mutant compared to N2 under 
pathogenic conditions. These qRT-PCR experiments were performed on RNA isolated from 
three biological replicates that were independent of the RNAseq RNA samples, yet there was a 
strong correlation between the results (Figure 5.1; R2=0.92 between fold change by RNAseq 
and qRT-PCR). Therefore, I believe that there were modest but significant effects on the 
transcriptome that implicate HPX-2 in cuticle biogenesis and defense against Gram-positive 
bacteria. 
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Through the RNAseq analysis, we were able to evaluate several subtle changes in 
global transcription compared to the N2 strain. First, when worms were under non-pathogenic 
conditions, no obvious physiological abnormalities was observed in the hpx-2 mutant. However, 
a large number of genes involved in cuticle biogenesis were differentially expressed according 
to RNAseq result, which explains the subtle increase in cuticle permeability phenotype observed 
in the hpx-2 mutant. Secondly, genes that are involved in locomotion were differentially 
expressed in the hpx-2 mutant under non-pathogenic conditions, suggesting a potential role for 
HPX-2 in regulating this process. Indeed, when hpx-2 was overexpressed in the worm, 
occasional dumpy and roller phenotypes were observed. Lastly, several components of the p38 
MAPK pathway were slightly induced in hpx-2 mutant, consistent with the overall increase in the 
innate response observed in the hpx-2 mutant. 
When comparing the pathogenic condition with the non-pathogenic, it was not surprising 
that a much larger set of genes were affected. Although the overall gene expression profile was 
not that different between N2 and hpx-2 when exposed to pathogen, a much stronger response 
was observed in the hpx-2 mutant, possibility due to the already disturbed physiological state in 
hpx-2 mutant.  The increased microbial load of E. faecalis in hpx-2 mutant could also explain 
why the transcriptional response was stronger compared to N2. Interestingly, the hpx-2 
transcript was not detectable in the N2 strain under non-pathogenic conditions, and was not 
induced following pathogen exposure. This again, highlights the specific expression pattern and 
tight regulation of hpx-2 (Table S3). Other genes encoding proteins involved in cuticle 
development like mlt-7 are expressed at intervals corresponding to the larval molts (29), and 
were not affected by the loss of HPX-2.  
In conclusion, RNAseq analysis revealed an altered gene expression profile in hpx-2 
mutant, consistent with a role in body morphogenesis, locomotion, and cuticle biogenesis. When 
exposed to the pathogen E. faecalis, loss hpx-2 resulted a stronger immune response 
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compared to N2 strain likely due to the more aggressive colonization by the pathogen that 
occurs in this background.  
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Chapter 6 Conclusions and Perspectives 
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Summary 
In this work, I characterized a putative peroxidase, HPX-2, for its immuno-protective role 
in C. elegans against multiple pathogens. Based on the expression pattern of HPX-2 and the 
tissue specific RNAi, I suspect HPX-2 functions in two major tissues, the pharynx and the 
hypodermis, for its function in preventing infections.  
In the pharynx, the HPX-2::GFP expression pattern revealed that HPX-2 is likely to be 
expressed in the gland cells located at the distal bulb of the pharynx. Gland cells function in 
secreting vesicles through the process into the pharyngeal lumen and aiding cuticle remodeling 
during the developmental process. Accordingly, loss of HPX-2 resulted in increased 
susceptibility to and intestinal colonization by the Gram-positive bacterium E. faecalis but not 
Gram-negative P. aeruginosa. The protective role of HPX-2 only applies to Gram-positive 
bacterial and fungal species, but not to Gram-negative bacteria, suggesting the thick outer layer 
of these pathogens could be the reason for this phenotype.  
In terms of hypodermis function, I first showed that tissue-specific knock down of HPX-2 
in the hypodermis significantly increased the susceptibility of worms to E. faecalis. Loss of HPX-
2 also resulted in a less intact cuticle as measured by a permeable DNA dye, suggesting again 
the role of HPX-2 in pathogen resistance is a function of cuticle reinforcement.  
Finally, I utilized RNAseq analysis as an un-biased and highly sensitive measurement of 
global transcriptomic changes upon the loss of HPX-2. The RNAseq results provided insight into 
the potential physiological processes HPX-2 is involved in.  Under non-pathogenic conditions, 
loss of hpx-2 resulted in a subtle but significant change in genes involved in cuticle biogenesis, 
locomotion, and molting, confirming the role of HPX-2 in cuticle biogenesis during development. 
Under pathogenic conditions, in addition to the enrichment of cuticle genes, there was 
significant induction of genes involved in innate immunity, suggesting a stronger immune 
response compared to N2 strain. Surprisingly, the expression level of hpx-2 is extremely low on 
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the organismal level resulting in hpx-2 gene reads being undetectable through RNAseq.  
However, the fact that loss of HPX-2 still results in dramatically increased sensitivity to the 
pathogen E. faecalis highlights its importance in innate immunity.  
In conclusion, I showed that HPX-2 is expressed in the pharynx and hypodermis of the 
worm strengthening the cuticle lining these organs and resulting in less colonization and 
multiplication of the pathogen in the intestine. 
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Discussions and future directions 
Cuticle reinforcement role of HPX-2 
Cuticle is the very outside layer that covers the worm body, and functions in protecting 
the worm from environmental insult, supporting the body structure, and facilitating locomotion 
through attachment with the underlying muscles (151-153). The body cuticle is secreted by the 
underlying hypodermal cells and has distinct layers and structures. The very outside layer of 
body cuticle is the surface coat majorly consisting of glycoproteins, whereas the remaining four 
layers underneath contain cross-linked collagens and cutlins proteins (30).  So far, a wide range 
of cuticle defective mutants have been identified and studied, which cause a variety of 
phenotypes, from altered body morphology, abnormal surface appearance, to pathogen 
resistance (30). 
In addition to the worm body, the four major openings of the worm (pharynx, vulva, anus, 
and excretory pore) are also covered with cuticle. However, unlike the body cuticle, opening-
lining cuticle lacks complex layers, and is mainly composed of soluble collagen proteins and 
insoluble cutlin proteins (30).  
As the major component of the cuticle, collagen proteins encompass up to 80% of the 
soluble proteins in the extracellular matrix. The C. elegans genome encodes for over 170 
collagen proteins (30). Thus far, 21 collagen-encoding genes have been shown to be involved in 
worm morphology (30). Mutation of these genes results in a variety of phenotypes including 
Dumpy (Dpy), Roller (rol), Blister (bli), and Squat (Sqt).  Surprisingly, 10 out of those 21 genes 
were significantly altered in hpx-2 mutant according to the RNAseq analysis, providing a strong 
indication that the loss of HPX-2 affects the overall cuticle structure and morphology of the 
worm. However, like the other genes that were differentially expressed in the hpx-2 mutant, the 
log2 fold-changes were not dramatic, most of them falling between one and two, suggesting a 
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subtle change. This could also explain why there were no visible morphology defects; only the 
Hoescht dye assay indicated a small disturbance in cuticle integrity (See chapter 4 for more 
detail).  
The cuticle is also the site of first contact between the worms and some pathogenic 
microbes that rely on the attachment and penetration of worm’s surface for their pathogenicity.  
Some components of the cuticle such as the carbohydrate-rich surface coat serve as a 
protective shield from pathogen attachment, and mutations in genes that are involved in 
production and secretion of these components result in increased pathogen susceptibility (50, 
154). For example, loss of function mutations in bacterially Un-Swollen genes bus-2, bus-4, bus-
12, and bus-17 increases attachment of the fungal pathogen Drechmeria coniospora spores to 
the cuticle (155), Microbacterium nematophilum to the rectal epithelia (156-159) and Yersinia 
pseudotuberculosis to the head (160, 161).  For the pathogens tested in this study, the site of 
infection was the intestine. It would be interesting to test the susceptibility of the hpx-2 mutant to 
cuticle pathogens, and such an investigation might provide more insight into HPX-2’s function in 
hypodermal immunity.  
While the body cuticle serves as the very first line of defense against environmental and 
microbial insult, the pharynx, especially the grinder, has a similar function against potential 
pathogens that are ingested. Studies have shown that mutants that have defective grinding 
function had increased uptake of intact microbes, resulting in higher susceptibility to pathogens 
(71, 162).  
In terms of the pharyngeal function of HPX-2, it is very likely that it plays the same role in 
hypodermis, specifically cuticle cross-linking, since the pharyngeal lumen including the grinder 
is lined with cuticle and it is connected to the cuticle of the hypodermis (30). By physical 
strengthening of the pharyngeal grinder, HPX-2 functions in pathogen resistance. Alternatively, 
HPX-2 could serve as a secreted peroxidase in the gland cells located in the distal bulb of the 
 104 
pharynx for cuticle grinder strengthening or aiding digestion of the microbe. While the cell body 
of the gland cells are embedded within the muscle cell epithelium at the distal bulb of the 
pharynx, there are structures, named processes, that protrude from the cell body and open into 
the pharyngeal lumen (135). During the molting process, the gland cells excrete vesicles that 
contains enzymes that aid in the tearing down of the old cuticle lining inside the pharynx and 
around the worm body (135, 136).  When feeding on bacteria, a different kind of vesicle is 
secreted to aid in digesting food (135). In chapter 4, I showed that the expression of HPX-
2::GFP in pharynx, specifically, the expression pattern resemble the gland cells in the pharynx 
in dauer worms and occasionally a protruding structure extending from the posterior bulb to the 
buccal cavity of the worms. It could be that HPX-2 is being produced in the gland cells located 
at the distal bulb and being secreted during molting and/or feeding.  
To further investigate whether HPX-2 is functioning in the physical reinforcement of the 
pharyngeal grinder or chemically aiding the digestion of microbes, it would be interesting to feed 
the worms with fluorescently-labeled beads that would normally be disrupted by a healthy 
grinder. If the intestinal fluorescence is stronger in hpx-2 mutant compared to N2 strain, it would 
indicate a less intact grinder in HPX-2 mutant. Alternatively, we could cross hpx-2 lines with 
those with known pharyngeal defects, i.e. the eat mutants, to see if there is an additive affect in 
pathogen susceptibility.  
 
The peroxidase activity of HPX-2 
In order to understand the mechanism of protection of HPX-2 in innate immunity, it is 
crucial to understand its enzymatic activity as a heme-peroxidase, specifically, the ability to 
utilize H2O2 as a substrate to carry out oxidation reactions. I first utilized Amplex Red Assay as a 
measurement for the level of H2O2 during infection. Previous studies showed that when exposed 
to pathogen, C. elegans produces elevated level of H2O2, and the deletion of a major 
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peroxidase could further increase H2O2 level (99, 102).  However, the Amplex Red Assay did not 
reveal an increased level of H2O2 in hpx-2 mutants when exposed to pathogen, suggesting 
HPX-2 is not a major consumer of H2O2 (Figure 4.8). On the other hand, the immune protective 
peroxidase previously identified in our lab, SKPO-1, was demonstrated to utilize H2O2 when 
worms where exposed to pathogen, because the level of H2O2 drastically increases in the skpo-
1 mutant. There are a couple of possible explanations for the fact that I did not detect changes 
in the H2O2 levels in the hpx-2 mutant. It could be because HPX-2 possesses little peroxidase 
activity under the conditions tested.  It also could be due to low levels of HPX-2 such that the 
Amplex Red Assay was not sensitive enough to detect a change.  Also, along the same line of 
reasoning, the fact that SKPO-1 is a major consumer of H2O2 during infection could mask the 
contribution of HPX-2’s peroxidase activity.  Last but not least, it’s likely that HPX-2 role 
happens early during development and it is not active in the adult animal.  
To test whether HPX-2’s peroxidase activity is required for pathogen resistance, a point 
mutation was generated in the hpx-2 gene through CRIPSR-cas9 mediated mutagenesis. 
Specifically, the catalytic arginine residue that is highly conserved throughout peroxidase-
cyclooxygenase superfamily was substituted with Alanine in HPX-2, resulting in a mutant protein 
in which peroxidase activity is expected to be lost (141, 163). Worms harboring the mutated 
version of HPX-2 exhibited increased susceptibility to pathogens (Figure 4. 9), indicating the 
peroxidase activity is required for HPX-2’ s immune protective role (see Chapter 4 for more 
detail)  
The natural next step in exploring the activity of HPX-2 is through in-vitro purification and 
enzymatic analysis of the protein.  Historically, using a baculovirus system in eukaryotic cells, 
multiple human peroxidases including MPO and LPO have been expressed (139). On the other 
hand, some studies showed that the peroxidase domain-containing proteins BLI-3 and MLT-7 
can be expressed and purified from an E. coli expression system with the peroxidase activity 
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intact  (28), (29). Given the lack of expertise in viral-mediated protein expression, I decided to 
try the E. coli expression system first. Unfortunately, my attempt at purifying the recombinant 
HPX-2 was not successful. One explanation for lack of good expression could be the 
differences in codon preference in E. coli versus C. elegans. To address this problem, we could 
order artificially synthesized, codon-optimized DNA, encoding HPX-2. Another potential problem 
with using the E. coli system is that peroxidases are usually heavily glycosylated during the 
post-translational process, and the modifications can be crucial for their full activity. In that case, 
a eukaryotic expression system may be the better choice for the expression and purification of 
fully active peroxidase.  
 
Potential involvement of HPX-2 in innate immune pathways 
Given the cuticle reinforcement function and potential peroxidase activity of HPX-2, there 
might be two non-mutually exclusive ways HPX-2 is involved in innate immunity. The first 
possibility is through the disturbed hypodermis and downstream signal pathway to activate the 
immune effectors. One example of this is the activation of AMP genes by the disruption of the 
hypodermis. Specifically, disruption of the hypodermis by fungal pathogen or in dpy-9 and dpy-
10 mutants results in an increased level of a tyrosine derivative 4-hydrophenyllactic acid 
(HPLA), which then activates its cognate G protein-coupled receptor (GPCR) DCAR-1 (84). The 
activation of DCAR-1 then triggers the expression of AMPs through p38 MAPK pathway and via 
the release of a negative regulator STA-2 (84, 164). Another example is from a recent study 
showing that disruption of specific structures of the cuticle triggers the activation of multiple 
stress response and innate immunity pathways (148). Specifically, disruption of the annular 
furrows by knocking down dpy-2, dpy-3, dpy-7, and dyp-10 genes activates detoxification, 
osmolyte resistance, and most importantly, antimicrobial responses in C. elegans (148). It was 
also discovered that multiple transcription factors act downstream of this process with 
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overlapping functions: i.e SKN-1/Nrf and ELT-3/GATA for detoxification, STA-2/stat and ELT-
3/GATA for antimicrobial gene expression (148). 
Intriguingly, one important observation from the RNAseq analysis is that the key player 
in the p38 MAPK, pmk-1, was induced upon the loss of HPX-2 under non-pathogenic 
conditions. In addition to pmk-1, genes that encode for the other two MAPK kinases, pmk-2 and 
pmk-3, were also upregulated 2 to 6-fold in the hpx-2 mutant compared to the N2 reference 
strain under the same conditions. This suggests that loss of HPX-2 had subtle but significant 
effects on the major immune signaling pathway. However, the physiological relevance of this 
effect requires further investigation.  
The other possible role for HPX-2 in innate immunity that I explored is production of an 
immune effector for pathogen elimination, in this case, a strong oxidant that could be derived 
from an oxidation reaction using H2O2 as a substrate.  As discussed in section 6.1 of this 
chapter, HPX-2 pharyngeal localization and the requirement of its catalytic residue for pathogen 
resistance indicate that HPX-2 might be serving as a catalytic enzyme aiding the digestion/ 
elimination of ingested pathogens. One way to further test this hypothesis is to purify HPX-2 and 
assay for its enzymatic activity against different substrates.  
 
Interactions with BLI-3 
To explore the possibility of physical interactions between BLI-3 and HPX-2, I first tried 
the yeast-two-hybrid method, in which I cloned the full-length HPX-2 and the peroxidase domain 
of BLI-3 into the yeast two hybrid vectors. However, I was not able to detect any interaction 
between BLI-3/SKPO-1 and BLI-3/HPX-2 (Figure 6.1 A and B). I reasoned that since BLI-3 and 
the peroxidases all have a predicted secretion signal peptide at their N terminus, they could be 
excreted out from yeast cells during production, contributing to a lack of detectable interactions. 
Hence, I cloned those genes without the signal peptide sequence into the yeast 2-hybrid 
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plasmids and tested their interactions. However, there was still no interaction detected (Figure 
6.1 C).  it could be that DUOXs are usually extensively glycosylated during protein synthesis 
and such modifications are critical for their cell surface expression activity such that the yeast 2-
hybrid system is not suitable (140). An alternative assay that could be used to explore this 
question further and has the advantage of being in vivo is the bimolecular fluorescence 
complementation (Bi-FC) assay (165).  Specifically, the BLI-3 peroxidase domain and its 
potential interacting peroxidases could be fused to two non-fluorescent fragments derived from 
a fluorescent protein. The constructs would then be delivered into C. elegans through 
microinjection. Fluorescent signals can be detected if there is an interaction between BLI-3 and 
the peroxidases. Last but not least, co-immunoprecipitation (co-IP) could be applied to 
investigate direct interaction between BLI-3 and HPX-2. It has been previously demonstrated 
that the peroxidase domain of hDUOX1 may mediate protein-protein interaction through its 
cysteine residues (166). Given its significant sequence homology with BLI-3, it is postulated the 
protein-protein interaction function of hDUOX1 might be conserved in BLI-3. A potential problem 
with this approach is that the extremely low expression of HPX-2 on the whole organism level 
will make the detection of an IP-ed product difficult.  
Although it is postulated that there might be direct interactions between BLI-3 and H2O2 
utilizing peroxidases, it could also be that direct physical interaction is not required for the 
function of peroxidases for the following reasons: First, H2O2 is a diffusible molecule that moves 
freely intracellularly and extracellularly following the concentration gradient. This makes H2O2 
easily accessible to peroxidases in proximity. Second, although BLI-3 is a membrane anchored 
protein, many peroxidases are secreted. Through temporal and spatial control of the 
peroxidases, a close proximity could be created between the two.  
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Figure 6.1 No interaction between BLI-3 and the two peroxidases (HPX-2 and SKPO-1) is 
detected by Yeast-2-hybrid. 
pOAD/pOBD-SKPO-1
pOAD/pOBD-BLI-3
pOBD/pOAD-SKPO-1
pOBD/pOAD-BLI-3
pOAD-SKPO-1/pOBD-BLI-3
pOAD-BLI-3/pOBD-SKPO-1
1175/1174
-Leu, -Trp -Leu, -Trp, -His
pOAD/pOBD-F09F3.5
pOAD/pOBD-BLI-3
pOBD/pOAD-F09F3.5
pOBD/pOAD-BLI-3
pOAD-F09F3.5/pOBD-BLI-3
pOAD-BLI-3/pOBD-F09F3.5
1175/1174
1175/1174
pOBD-SKPO1’/pOAD-BLI-3
pOAD-P1’/pOBD-BLI-3
-Leu, -Trp -Leu, -Trp, -His
-Leu, -Trp -Leu, -Trp, -His
A
B
C
 110 
REFERENCES  
1. Izydor Apostol, P. F. H., and Philip S. Low. (1989) Rapid Stimulation of an 
Oxidative Burst during Elicitation of Cultured Plant Cells. PlantPhysiol 90, 109-
116 
2. Levine, A., Tenhaken, R., Dixon, R., and Lamb, C. (1994) H2O2 from the 
oxidative burst orchestrates the plant hypersensitive disease resistance 
response. Cell 79, 583-593 
3. Rojas, C., and Mysore, K. S. (2012) Glycolate oxidase is an alternative source for 
H2O2 production during plant defense responses and functions independently 
from NADPH oxidase. Plant signaling & behavior 7, 752-755 
4. Rojas, C. M., Senthil-Kumar, M., Wang, K., Ryu, C. M., Kaundal, A., and Mysore, 
K. S. (2012) Glycolate oxidase modulates reactive oxygen species-mediated 
signal transduction during nonhost resistance in Nicotiana benthamiana and 
Arabidopsis. The Plant cell 24, 336-352 
5. Levine, A., Pennell, R. I., Alvarez, M. E., Palmer, R., and Lamb, C. (1996) 
Calcium-mediated apoptosis in a plant hypersensitive disease resistance 
response. Current biology: CB 6, 427-437 
6. Dong, W. E. D. a. X. (2004) Systemic Acquired Resistance Annu. Rev. 
Phytopathol. 42, 185-209 
7. Buchon, N., Broderick, N. A., Poidevin, M., Pradervand, S., and Lemaitre, B. 
(2009) Drosophila Intestinal Response to Bacterial Infection: Activation of Host 
Defense and Stem Cell Proliferation. Cell Host & Microbe 5, 200-211 
8. Wu, S.-C., Liao, C.-W., Pan, R.-L., and Juang, J.-L. (2012) Infection-Induced 
Intestinal Oxidative Stress Triggers Organ-to-Organ Immunological 
Communication in Drosophila. Cell Host & Microbe 11, 410-417 
9. Niethammer, P., Grabher, C., Look, A. T., and Mitchison, T. J. (2009) A tissue-
scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. 
Nature 459, 996-999 
10. Schreck, R., Rieber, P., and Baeuerle, P. A. (1991) Reactive oxygen 
intermediates as apparently widely used messengers in the activation of the NF-
kappa B transcription factor and HIV-1. The EMBO journal 10, 2247-2258 
11. Lipinski, S., Till, A., Sina, C., Arlt, A., Grasberger, H., Schreiber, S., and 
Rosenstiel, P. (2009) DUOX2-derived reactive oxygen species are effectors of 
NOD2-mediated antibacterial responses. Journal of cell science 122, 3522-3530 
 111 
12. Klebanoff, S. J., Kettle, A. J., Rosen, H., Winterbourn, C. C., and Nauseef, W. M. 
(2013) Myeloperoxidase: a front-line defender against phagocytosed 
microorganisms. Journal of leukocyte biology 93, 185-198 
13. Chapman, A. L., Hampton, M. B., Senthilmohan, R., Winterbourn, C. C., and 
Kettle, A. J. (2002) Chlorination of bacterial and neutrophil proteins during 
phagocytosis and killing of Staphylococcus aureus. The Journal of biological 
chemistry 277, 9757-9762 
14. Rosen, H., Crowley, J. R., and Heinecke, J. W. (2002) Human neutrophils use 
the myeloperoxidase-hydrogen peroxide-chloride system to chlorinate but not 
nitrate bacterial proteins during phagocytosis. The Journal of biological chemistry 
277, 30463-30468 
15. Gerson, C., Sabater, J., Scuri, M., Torbati, A., Coffey, R., Abraham, J. W., 
Lauredo, I., Forteza, R., Wanner, A., Salathe, M., Abraham, W. M., and Conner, 
G. E. (2000) The lactoperoxidase system functions in bacterial clearance of 
airways. American journal of respiratory cell and molecular biology 22, 665-671 
16. Geiszt, M., Witta, J., Baffi, J., Lekstrom, K., and Leto, T. L. (2003) Dual oxidases 
represent novel hydrogen peroxide sources supporting mucosal surface host 
defense. Faseb J 17, 1502-1504 
17. Forteza, R., Salathe, M., Miot, F., and Conner, G. E. (2005) Regulated hydrogen 
peroxide production by Duox in human airway epithelial cells. American journal of 
respiratory cell and molecular biology 32, 462-469 
18. Conner, G. E., Salathe, M., and Forteza, R. (2002) Lactoperoxidase and 
hydrogen peroxide metabolism in the airway. American journal of respiratory and 
critical care medicine 166, S57-61 
19. Rada, B., and Leto, T. L. (2010) Characterization of hydrogen peroxide 
production by Duox in bronchial epithelial cells exposed to Pseudomonas 
aeruginosa. FEBS letters 584, 917-922 
20. Moskwa, P., Lorentzen, D., Excoffon, K. J., Zabner, J., McCray, P. B., Jr., 
Nauseef, W. M., Dupuy, C., and Banfi, B. (2007) A novel host defense system of 
airways is defective in cystic fibrosis. American journal of respiratory and critical 
care medicine 175, 174-183 
21. Bedard, K., and Krause, K. H. (2007) The NOX family of ROS-generating 
NADPH oxidases: physiology and pathophysiology. Physiological reviews 87, 
245-313 
22. Lambeth, J. D. (2004) NOX enzymes and the biology of reactive oxygen. Nature 
reviews. Immunology 4, 181-189 
 112 
23. Lambeth, J. D., and Neish, A. S. (2014) Nox enzymes and new thinking on 
reactive oxygen: a double-edged sword revisited. Annual review of pathology 9, 
119-145 
24. Jackson, S. H., Gallin, J. I., and Holland, S. M. (1995) The p47phox mouse 
knock-out model of chronic granulomatous disease. The Journal of experimental 
medicine 182, 751-758 
25. Krause, K. H. (2004) Tissue distribution and putative physiological function of 
NOX family NADPH oxidases. Japanese journal of infectious diseases 57, S28-
29 
26. Anh, N. T., Nishitani, M., Harada, S., Yamaguchi, M., and Kamei, K. (2011) 
Essential role of Duox in stabilization of Drosophila wing. The Journal of 
biological chemistry 286, 33244-33251 
27. Kumar, S., Molina-Cruz, A., Gupta, L., Rodrigues, J., and Barillas-Mury, C. 
(2010) A peroxidase/dual oxidase system modulates midgut epithelial immunity 
in Anopheles gambiae. Science (New York, N.Y.) 327, 1644-1648 
28. Edens, W. A., Sharling, L., Cheng, G., Shapira, R., Kinkade, J. M., Lee, T., 
Edens, H. A., Tang, X., Sullards, C., Flaherty, D. B., Benian, G. M., and Lambeth, 
J. D. (2001) Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a 
multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit 
gp91phox. J Cell Biol 154, 879-891 
29. Thein, M. C., Winter, A. D., Stepek, G., McCormack, G., Stapleton, G., 
Johnstone, I. L., and Page, A. P. (2009) Combined extracellular matrix cross-
linking activity of the peroxidase MLT-7 and the dual oxidase BLI-3 is critical for 
post-embryonic viability in Caenorhabditis elegans. The Journal of biological 
chemistry 284, 17549-17563 
30. Page, A. P., and Johnstone, I. L. (2007) The cuticle. WormBook : the online 
review of C. elegans biology, 1-15 
31. Ewald, C. Y. (2018) Redox Signaling of NADPH Oxidases Regulates Oxidative 
Stress Responses, Immunity and Aging. Antioxidants (Basel, Switzerland) 7 
32. Zamocky, M., Hofbauer, S., Schaffner, I., Gasselhuber, B., Nicolussi, A., Soudi, 
M., Pirker, K. F., Furtmuller, P. G., and Obinger, C. (2015) Independent evolution 
of four heme peroxidase superfamilies. Archives of biochemistry and biophysics 
574, 108-119 
33. Colas, C., and Ortiz de Montellano, P. R. (2003) Autocatalytic radical reactions in 
physiological prosthetic heme modification. Chemical reviews 103, 2305-2332 
 113 
34. Finzel, B. C., Poulos, T. L., and Kraut, J. (1984) Crystal structure of yeast 
cytochrome c peroxidase refined at 1.7-A resolution. The Journal of biological 
chemistry 259, 13027-13036 
35. Gajhede, M., Schuller, D. J., Henriksen, A., Smith, A. T., and Poulos, T. L. (1997) 
Crystal structure of horseradish peroxidase C at 2.15 A resolution. Nature 
structural biology 4, 1032-1038 
36. Meitzler, J. L., Brandman, R., and Ortiz de Montellano, P. R. (2010) Perturbed 
heme binding is responsible for the blistering phenotype associated with 
mutations in the Caenorhabditis elegans dual oxidase 1 (DUOX1) peroxidase 
domain. The Journal of biological chemistry 285, 40991-41000 
37. Harman, D. (2003) The free radical theory of aging. Antioxidants & redox 
signaling 5, 557-561 
38. Dan Dunn, J., Alvarez, L. A., Zhang, X., and Soldati, T. (2015) Reactive oxygen 
species and mitochondria: A nexus of cellular homeostasis. Redox biology 6, 
472-485 
39. Pinegin, B., Vorobjeva, N., Pashenkov, M., and Chernyak, B. (2018) The role of 
mitochondrial ROS in antibacterial immunity. Journal of cellular physiology 233, 
3745-3754 
40. Yee, C., Yang, W., and Hekimi, S. (2014) The intrinsic apoptosis pathway 
mediates the pro-longevity response to mitochondrial ROS in C. elegans. Cell 
157, 897-909 
41. Xu, S., and Chisholm, A. D. (2014) C. elegans epidermal wounding induces a 
mitochondrial ROS burst that promotes wound repair. Developmental cell 31, 48-
60 
42. West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., 
Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., and Ghosh, S. (2011) TLR 
signalling augments macrophage bactericidal activity through mitochondrial ROS. 
Nature 472, 476-480 
43. Geng, J., Sun, X., Wang, P., Zhang, S., Wang, X., Wu, H., Hong, L., Xie, C., Li, 
X., Zhao, H., Liu, Q., Jiang, M., Chen, Q., Zhang, J., Li, Y., Song, S., Wang, H. 
R., Zhou, R., Johnson, R. L., Chien, K. Y., Lin, S. C., Han, J., Avruch, J., Chen, 
L., and Zhou, D. (2015) Kinases Mst1 and Mst2 positively regulate phagocytic 
induction of reactive oxygen species and bactericidal activity. Nature immunology 
16, 1142-1152 
44. West, A. P., Shadel, G. S., and Ghosh, S. (2011) Mitochondria in innate immune 
responses. Nature reviews. Immunology 11, 389-402 
 114 
45. Dharmawardhane, S., and Bokoch, G. M. (1997) Rho GTPases and leukocyte 
cytoskeletal regulation. Current opinion in hematology 4, 12-18 
46. Williams, D. A., Tao, W., Yang, F., Kim, C., Gu, Y., Mansfield, P., Levine, J. E., 
Petryniak, B., Derrow, C. W., Harris, C., Jia, B., Zheng, Y., Ambruso, D. R., 
Lowe, J. B., Atkinson, S. J., Dinauer, M. C., and Boxer, L. (2000) Dominant 
negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is 
associated with a human phagocyte immunodeficiency. Blood 96, 1646-1654 
47. Sulston, J. E., Schierenberg, E., White, J. G., and Thomson, J. N. (1983) The 
embryonic cell lineage of the nematode Caenorhabditis elegans. Developmental 
biology 100, 64-119 
48. Ellis, H. M., and Horvitz, H. R. (1986) Genetic control of programmed cell death 
in the nematode C. elegans. Cell 44, 817-829 
49. Brenner, S. (1974) The genetics of Caenorhabditis elegans. Genetics 77, 71-94 
50. Jiang, H., and Wang, D. (2018) The Microbial Zoo in the C. elegans Intestine: 
Bacteria, Fungi and Viruses. Viruses 10 
51. Pukkila-Worley, R. A., F.M.; Mylonakis. (2011) Candida albicans infection of 
Caenorhabditis elegans induces antifungal immune defenses 
. PLoS pathogens, e1002074 
52. Tang, R. J., Breger, J., Idnurm, A., Gerik, K. J., Lodge, J. K., Heitman, J., 
Calderwood, S. B., and Mylonakis, E. (2005) Cryptococcus neoformans gene 
involved in mammalian pathogenesis identified by a Caenorhabditis elegans 
progeny-based approach. Infection and immunity 73, 8219-8225 
53. Mylonakis, E., Ausubel, F. M., Perfect, J. R., Heitman, J., and Calderwood, S. B. 
(2002) Killing of Caenorhabditis elegans by Cryptococcus neoformans as a 
model of yeast pathogenesis. Proceedings of the National Academy of Sciences 
of the United States of America 99, 15675-15680 
54. Jansson, H. B. (1994) Adhesion of conidia of Drechmeria coniospora to 
Caenorhabditis elegans wild type and mutants. Journal of nematology 26, 430-
435 
55. Mahajan-Miklos, S., Tan, M. W., Rahme, L. G., and Ausubel, F. M. (1999) 
Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas 
aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96, 47-56 
56. Tan, M. W., Mahajan-Miklos, S., and Ausubel, F. M. (1999) Killing of 
Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian 
 115 
bacterial pathogenesis. Proceedings of the National Academy of Sciences of the 
United States of America 96, 715-720 
57. Youn, M., Lee, K. M., Kim, S. H., Lim, J., Yoon, J. W., and Park, S. (2013) 
Escherichia coli O157:H7 LPS O-side chains and pO157 are required for killing 
Caenorhabditis elegans. Biochemical and biophysical research communications 
436, 388-393 
58. Wei, J. Z., Hale, K., Carta, L., Platzer, E., Wong, C., Fang, S. C., and Aroian, R. 
V. (2003) Bacillus thuringiensis crystal proteins that target nematodes. 
Proceedings of the National Academy of Sciences of the United States of 
America 100, 2760-2765 
59. Sifri, C. D., Begun, J., Ausubel, F. M., and Calderwood, S. B. (2003) 
Caenorhabditis elegans as a model host for Staphylococcus aureus 
pathogenesis. Infection and immunity 71, 2208-2217 
60. Jansen, W. T., Bolm, M., Balling, R., Chhatwal, G. S., and Schnabel, R. (2002) 
Hydrogen peroxide-mediated killing of Caenorhabditis elegans by Streptococcus 
pyogenes. Infection and immunity 70, 5202-5207 
61. Garsin, D. A., Villanueva, J. M., Begun, J., Kim, D. H., Sifri, C. D., Calderwood, 
S. B., Ruvkun, G., and Ausubel, F. M. (2003) Long-lived C. elegans daf-2 
mutants are resistant to bacterial pathogens. Science (New York, N.Y.) 300, 
1921 
62. Garsin, D. A., Sifri, C. D., Mylonakis, E., Qin, X., Singh, K. V., Murray, B. E., 
Calderwood, S. B., and Ausubel, F. M. (2001) A simple model host for identifying 
Gram-positive virulence factors. Proceedings of the National Academy of 
Sciences of the United States of America 98, 10892-10897 
63. Sifri, C. D., Mylonakis, E., Singh, K. V., Qin, X., Garsin, D. A., Murray, B. E., 
Ausubel, F. M., and Calderwood, S. B. (2002) Virulence effect of Enterococcus 
faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis 
elegans and mice. Infection and immunity 70, 5647-5650 
64. Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., and Ausubel, F. M. 
(2006) Identification of novel antimicrobials using a live-animal infection model. 
Proceedings of the National Academy of Sciences of the United States of 
America 103, 10414-10419 
65. Xu, A., Shi, G., Liu, F., and Ge, B. (2013) Caenorhabditis elegans mom-4 is 
required for the activation of the p38 MAPK signaling pathway in the response to 
Pseudomonas aeruginosa infection. Protein & cell 4, 53-61 
 116 
66. Powell, J. R., Kim, D. H., and Ausubel, F. M. (2009) The G protein-coupled 
receptor FSHR-1 is required for the Caenorhabditis elegans innate immune 
response. Proceedings of the National Academy of Sciences of the United States 
of America 106, 2782-2787 
67. Estes, K. A., Dunbar, T. L., Powell, J. R., Ausubel, F. M., and Troemel, E. R. 
(2010) bZIP transcription factor zip-2 mediates an early response to 
Pseudomonas aeruginosa infection in Caenorhabditis elegans. Proceedings of 
the National Academy of Sciences of the United States of America 107, 2153-
2158 
68. Aballay, A., Drenkard, E., Hilbun, L. R., and Ausubel, F. M. (2003) 
Caenorhabditis elegans innate immune response triggered by Salmonella 
enterica requires intact LPS and is mediated by a MAPK signaling pathway. 
Current biology : CB 13, 47-52 
69. Bae, T., Banger, A. K., Wallace, A., Glass, E. M., Aslund, F., Schneewind, O., 
and Missiakas, D. M. (2004) Staphylococcus aureus virulence genes identified by 
bursa aurealis mutagenesis and nematode killing. Proceedings of the National 
Academy of Sciences of the United States of America 101, 12312-12317 
70. Broadway, M. M., Rogers, E. A., Chang, C., Huang, I. H., Dwivedi, P., Yildirim, 
S., Schmitt, M. P., Das, A., and Ton-That, H. (2013) Pilus gene pool variation and 
the virulence of Corynebacterium diphtheriae clinical isolates during infection of a 
nematode. Journal of bacteriology 195, 3774-3783 
71. Kim, D. H., Feinbaum, R., Alloing, G., Emerson, F. E., Garsin, D. A., Inoue, H., 
Tanaka-Hino, M., Hisamoto, N., Matsumoto, K., Tan, M. W., and Ausubel, F. M. 
(2002) A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate 
immunity. Science (New York, N.Y.) 297, 623-626 
72. Garsin, D. A., Frank, K. L., Silanpaa, J., Ausubel, F. M., Hartke, A., Shankar, N., 
and Murray, B. E. (2014) Pathogenesis and Models of Enterococcal Infection. In 
Enterococci: From Commensals to Leading Causes of Drug Resistant Infection 
(Gilmore, M. S., Clewell, D. B., Ike, Y., and Shankar, N., eds), Boston 
73. Medzhitov, R., and Janeway, C. A., Jr. (1998) An ancient system of host 
defense. Current opinion in immunology 10, 12-15 
74. Seong, S. Y., and Matzinger, P. (2004) Hydrophobicity: an ancient damage-
associated molecular pattern that initiates innate immune responses. Nature 
reviews. Immunology 4, 469-478 
75. Matzinger, P. (2002) The danger model: a renewed sense of self. Science (New 
York, N.Y.) 296, 301-305 
 117 
76. Brandt, J. P., and Ringstad, N. (2015) Toll-like Receptor Signaling Promotes 
Development and Function of Sensory Neurons Required for a C. elegans 
Pathogen-Avoidance Behavior. Current biology : CB 25, 2228-2237 
77. Kurz, C. L., and Ewbank, J. J. (2003) Caenorhabditis elegans: an emerging 
genetic model for the study of innate immunity. Nature reviews. Genetics 4, 380-
390 
78. Pukkila-Worley, R., Peleg, A. Y., Tampakakis, E., and Mylonakis, E. (2009) 
Candida albicans hyphal formation and virulence assessed using a 
Caenorhabditis elegans infection model. Eukaryot Cell 8, 1750-1758 
79. Yuen, G. J., and Ausubel, F. M. (2018) Both live and dead Enterococci activate 
Caenorhabditis elegans host defense via immune and stress pathways. 
Virulence 9, 683-699 
80. Miller, E. V., Grandi, L. N., Giannini, J. A., Robinson, J. D., and Powell, J. R. 
(2015) The Conserved G-Protein Coupled Receptor FSHR-1 Regulates 
Protective Host Responses to Infection and Oxidative Stress. PloS one 10, 
e0137403 
81. Pujol, N., Zugasti, O., Wong, D., Couillault, C., Kurz, C. L., Schulenburg, H., and 
Ewbank, J. J. (2008) Anti-fungal innate immunity in C. elegans is enhanced by 
evolutionary diversification of antimicrobial peptides. PLoS pathogens 4, 
e1000105 
82. Pujol, N., Cypowyj, S., Ziegler, K., Millet, A., Astrain, A., Goncharov, A., Jin, Y., 
Chisholm, A. D., and Ewbank, J. J. (2008) Distinct innate immune responses to 
infection and wounding in the C. elegans epidermis. Current biology : CB 18, 
481-489 
83. Bischof, L. J., Kao, C. Y., Los, F. C., Gonzalez, M. R., Shen, Z., Briggs, S. P., 
van der Goot, F. G., and Aroian, R. V. (2008) Activation of the unfolded protein 
response is required for defenses against bacterial pore-forming toxin in vivo. 
PLoS pathogens 4, e1000176 
84. Zugasti, O., Bose, N., Squiban, B., Belougne, J., Kurz, C. L., Schroeder, F. C., 
Pujol, N., and Ewbank, J. J. (2014) Activation of a G protein-coupled receptor by 
its endogenous ligand triggers the innate immune response of Caenorhabditis 
elegans. Nature immunology 15, 833-838 
85. Posas, F., and Saito, H. (1997) Osmotic activation of the HOG MAPK pathway 
via Ste11p MAPKKK: scaffold role of Pbs2p MAPKK. Science (New York, N.Y.) 
276, 1702-1705 
 118 
86. Huang, G., Shi, L. Z., and Chi, H. (2009) Regulation of JNK and p38 MAPK in the 
immune system: signal integration, propagation and termination. Cytokine 48, 
161-169 
87. Keshet, Y., and Seger, R. (2010) The MAP kinase signaling cascades: a system 
of hundreds of components regulates a diverse array of physiological functions. 
Methods in molecular biology (Clifton, N.J.) 661, 3-38 
88. Troemel, E. R., Chu, S. W., Reinke, V., Lee, S. S., Ausubel, F. M., and Kim, D. 
H. (2006) p38 MAPK Regulates Expression of Immune Response Genes and 
Contributes to Longevity in C. elegans. PLoS genetics in press 
89. Shivers, R. P., Pagano, D. J., Kooistra, T., Richardson, C. E., Reddy, K. C., 
Whitney, J. K., Kamanzi, O., Matsumoto, K., Hisamoto, N., and Kim, D. H. (2010) 
Phosphorylation of the conserved transcription factor ATF-7 by PMK-1 p38 
MAPK regulates innate immunity in Caenorhabditis elegans. PLoS genetics 6, 
e1000892 
90. Kim, D. H., Liberati, N. T., Mizuno, T., Inoue, H., Hisamoto, N., Matsumoto, K., 
and Ausubel, F. M. (2004) Integration of Caenorhabditis elegans MAPK 
pathways mediating immunity and stress resistance by MEK-1 MAPK kinase and 
VHP-1 MAPK phosphatase. Proceedings of the National Academy of Sciences of 
the United States of America 101, 10990-10994 
91. Wolkow, C. A., Kimura, K. D., Lee, M. S., and Ruvkun, G. (2000) Regulation of 
C. elegans life-span by insulinlike signaling in the nervous system. Science (New 
York, N.Y.) 290, 147-150 
92. Antebi, A. (2007) Genetics of aging in Caenorhabditis elegans. PLoS genetics 3, 
1565-1571 
93. Banyai, L., and Patthy, L. (1998) Amoebapore homologs of Caenorhabditis 
elegans. Biochimica et biophysica acta 1429, 259-264 
94. Kato, Y., Aizawa, T., Hoshino, H., Kawano, K., Nitta, K., and Zhang, H. (2002) 
abf-1 and abf-2, ASABF-type antimicrobial peptide genes in Caenorhabditis 
elegans. Biochemical Journal 361, 221-230 
95. Mallo, G. V., Kurz, C. L., Couillault, C., Pujol, N., Granjeaud, S., Kohara, Y., and 
Ewbank, J. J. (2002) Inducible Antibacterial Defense System in C. elegans. 
Current biology : CB 12, 1209-1214 
96. Simonsen, K. T., Gallego, S. F., Faergeman, N. J., and Kallipolitis, B. H. (2012) 
Strength in numbers: "Omics" studies of C. elegans innate immunity. Virulence 3, 
477-484 
 119 
97. Miltsch, S. M., Seeberger, P. H., and Lepenies, B. (2014) The C-type lectin-like 
domain containing proteins Clec-39 and Clec-49 are crucial for Caenorhabditis 
elegans immunity against Serratia marcescens infection. Developmental and 
comparative immunology 45, 67-73 
98. Chavez, V., Mohri-Shiomi, A., Maadani, A., Vega, L. A., and Garsin, D. A. (2007) 
Oxidative stress enzymes are required for DAF-16-mediated immunity due to 
generation of reactive oxygen species by Caenorhabditis elegans. Genetics 176, 
1567-1577 
99. Chavez, V., Mohri-Shiomi, A., and Garsin, D. A. (2009) Ce-Duox1/BLI-3 
generates reactive oxygen species as a protective innate immune mechanism in 
Caenorhabditis elegans. Infection and immunity 77, 4983-4989 
100. van der Hoeven, R., Cruz, M. R., Chavez, V., and Garsin, D. A. (2015) 
Localization of the Dual Oxidase BLI-3 and Characterization of Its NADPH 
Oxidase Domain during Infection of Caenorhabditis elegans. PloS one 10, 
e0124091 
101. van der Hoeven, R., McCallum, K. C., Cruz, M. R., and Garsin, D. A. (2011) Ce-
Duox1/BLI-3 Generated Reactive Oxygen Species Trigger Protective SKN-1 
Activity via p38 MAPK Signaling during Infection in C. elegans. PLoS pathogens 
7, e1002453 
102. Tiller, G. R., and Garsin, D. A. (2014) The SKPO-1 Peroxidase Functions in the 
Hypodermis to Protect Caenorhabditis elegans From Bacterial Infection. 
Genetics 197, 515-526 
103. Hoeven, R., McCallum, K. C., Cruz, M. R., and Garsin, D. A. (2011) Ce-
Duox1/BLI-3 generated reactive oxygen species trigger protective SKN-1 activity 
via p38 MAPK signaling during infection in C. elegans. PLoS pathogens 7, 
e1002453 
104. Hope, I. A. (1999) C. elegans A Practical Approach, Oxford University Press, 
Oxford 
105. Ward, J. D. (2015) Rapid and precise engineering of the Caenorhabditis elegans 
genome with lethal mutation co-conversion and inactivation of NHEJ repair. 
Genetics 199, 363-377 
106. Kage-Nakadai, E., Kobuna, H., Funatsu, O., Otori, M., Gengyo-Ando, K., 
Yoshina, S., Hori, S., and Mitani, S. (2012) Single/low-copy integration of 
transgenes in Caenorhabditis elegans using an ultraviolet trimethylpsoralen 
method. BMC Biotechnol 12, 1 
 120 
107. Powell, J. R., and Ausubel, F. M. (2008) Models of Caenorhabditis elegans 
infection by bacterial and fungal pathogens. Methods in molecular biology 
(Clifton, N.J.) 415, 403-427 
108. Cruz, M. R., Graham, C. E., Gagliano, B. C., Lorenz, M. C., and Garsin, D. A. 
(2013) Enterococcus faecalis inhibits hyphal morphogenesis and virulence of 
Candida albicans. Infection and immunity 81, 189-200 
109. Tiller, G. R., and Garsin, D. A. (2014) Of Worms and Men: HLH-30 and TFEB 
Regulate Tolerance to Infection. Immunity 40, 857-858 
110. Moribe, H., Yochem, J., Yamada, H., Tabuse, Y., Fujimoto, T., and Mekada, E. 
(2004) Tetraspanin protein (TSP-15) is required for epidermal integrity in 
Caenorhabditis elegans. Journal of cell science 117, 5209-5220 
111. Trapnell, C., Pachter, L., and Salzberg, S. L. (2009) TopHat: discovering splice 
junctions with RNA-Seq. Bioinformatics 25, 1105-1111 
112. Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. 
J., Salzberg, S. L., Wold, B. J., and Pachter, L. (2010) Transcript assembly and 
quantification by RNA-Seq reveals unannotated transcripts and isoform switching 
during cell differentiation. Nature biotechnology 28, 511-515 
113. Huang, D. W., Sherman, B. T., Tan, Q., Collins, J. R., Alvord, W. G., Roayaei, J., 
Stephens, R., Baseler, M. W., Lane, H. C., and Lempicki, R. A. (2007) The 
DAVID Gene Functional Classification Tool: a novel biological module-centric 
algorithm to functionally analyze large gene lists. Genome Biol 8, R183 
114. Dunny, G. M., Brown, B. L., and Clewell, D. B. (1978) Induced cell aggregation 
and mating in Streptococcus faecalis: evidence for a bacterial sex pheromone. 
Proceedings of the National Academy of Sciences of the United States of 
America 75, 3479-3483 
115. Debroy, S., van der Hoeven, R., Singh, K. V., Gao, P., Harvey, B. R., Murray, B. 
E., and Garsin, D. A. (2012) Development of a genomic site for gene integration 
and expression in Enterococcus faecalis. Journal of microbiological methods 90, 
1-8 
116. Rahme, L. G., Stevens, E. J., Wolfort, S. F., Shao, J., Tompkins, R. G., and 
Ausubel, F. M. (1995) Common virulence factors for bacterial pathogenicity in 
plants and animals [see comments]. Science (New York, N.Y.) 268, 1899-1902 
117. Kirienko, N. V., Kirienko, D. R., Larkins-Ford, J., Wahlby, C., Ruvkun, G., and 
Ausubel, F. M. (2013) Pseudomonas aeruginosa disrupts Caenorhabditis 
elegans iron homeostasis, causing a hypoxic response and death. Cell Host 
Microbe 13, 406-416 
 121 
118. Hayashi, T., Makino, K., Ohnishi, M., Kurokawa, K., Ishii, K., Yokoyama, K., Han, 
C. G., Ohtsubo, E., Nakayama, K., Murata, T., Tanaka, M., Tobe, T., Iida, T., 
Takami, H., Honda, T., Sasakawa, C., Ogasawara, N., Yasunaga, T., Kuhara, S., 
Shiba, T., Hattori, M., and Shinagawa, H. (2001) Complete genome sequence of 
enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a 
laboratory strain K-12. DNA Res 8, 11-22 
119. Makino, K., Ishii, K., Yasunaga, T., Hattori, M., Yokoyama, K., Yutsudo, C. H., 
Kubota, Y., Yamaichi, Y., Iida, T., Yamamoto, K., Honda, T., Han, C. G., 
Ohtsubo, E., Kasamatsu, M., Hayashi, T., Kuhara, S., and Shinagawa, H. (1998) 
Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an 
enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak. DNA 
Res 5, 1-9 
120. Fonzi, W. A., and Irwin, M. Y. (1993) Isogenic strain construction and gene 
mapping in Candida albicans. Genetics 134, 717-728 
121. Novick, R. P. (1963) ANALYSIS BY TRANSDUCTION OF MUTATIONS 
AFFECTING PENICILLINASE FORMATION IN STAPHYLOCOCCUS AUREUS. 
J Gen Microbiol 33, 121-136 
122. Hoiseth, S. K., and Stocker, B. A. (1981) Aromatic-dependent Salmonella 
typhimurium are non-virulent and effective as live vaccines. Nature 291, 238-239 
123. Cerdeno-Tarraga, A. M., Efstratiou, A., Dover, L. G., Holden, M. T., Pallen, M., 
Bentley, S. D., Besra, G. S., Churcher, C., James, K. D., De Zoysa, A., 
Chillingworth, T., Cronin, A., Dowd, L., Feltwell, T., Hamlin, N., Holroyd, S., 
Jagels, K., Moule, S., Quail, M. A., Rabbinowitsch, E., Rutherford, K. M., 
Thomson, N. R., Unwin, L., Whitehead, S., Barrell, B. G., and Parkhill, J. (2003) 
The complete genome sequence and analysis of Corynebacterium diphtheriae 
NCTC13129. Nucleic acids research 31, 6516-6523 
124. Melo, J. A., and Ruvkun, G. (2012) Inactivation of conserved C. elegans genes 
engages pathogen- and xenobiotic-associated defenses. Cell 149, 452-466 
125. Rada, B., Lekstrom, K., Damian, S., Dupuy, C., and Leto, T. L. (2008) The 
Pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial 
system as it imposes oxidative stress on airway epithelial cells. Journal of 
immunology (Baltimore, Md. : 1950) 181, 4883-4893 
126. Klebanoff, S. J. (2005) Myeloperoxidase: friend and foe. Journal of leukocyte 
biology 77, 598-625 
127. Forteza, R., Salathe, M., Miot, F., Forteza, R., and Conner, G. E. (2005) 
Regulated hydrogen peroxide production by Duox in human airway epithelial 
cells. American journal of respiratory cell and molecular biology 32, 462-469 
 122 
128. Torres, M. A., Jones, J. D., and Dangl, J. L. (2006) Reactive oxygen species 
signaling in response to pathogens. Plant physiology 141, 373-378 
129. McCallum, K. C., and Garsin, D. A. (2016) The Role of Reactive Oxygen Species 
in Modulating the Caenorhabditis elegans Immune Response. PLoS pathogens 
12, e1005923 
130. Fraser, A. G., Kamath, R. S., Zipperlen, P., Martinez-Campos, M., Sohrmann, M., 
and Ahringer, J. (2000) Functional genomic analysis of C. elegans chromosome I 
by systematic RNA interference. Nature 408, 325-330 
131. Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., 
Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M., Welchman, D. P., Zipperlen, 
P., and Ahringer, J. (2003) Systematic functional analysis of the Caenorhabditis 
elegans genome using RNAi. Nature 421, 231-237 
132. Garigan, D., Hsu, A. L., Fraser, A. G., Kamath, R. S., Ahringer, J., and Kenyon, 
C. (2002) Genetic analysis of tissue aging in Caenorhabditis elegans: a role for 
heat-shock factor and bacterial proliferation. Genetics 161, 1101-1112 
133. Mello, C. C., Kramer, J. M., Stinchcomb, D., and Ambros, V. (1991) Efficient 
gene transfer in C.elegans: extrachromosomal maintenance and integration of 
transforming sequences. The EMBO journal 10, 3959-3970 
134. Herndon, L. A., Crocker, C., Hall, D. H., and Altun, Z. (2012) Pharynx Atlas. 
Wormatlas  
135. Albertson, D. G., and Thomson, J. N. (1976) The pharynx of Caenorhabditis 
elegans. Philosophical transactions of the Royal Society of London. Series B, 
Biological sciences 275, 299-325 
136. Hall, D. H., and Hedgecock, E. M. (1991) Kinesin-related gene unc-104 is 
required for axonal transport of synaptic vesicles in C. elegans. Cell 65, 837-847 
137. Kage-Nakadai, E., Kobuna, H., Kimura, M., Gengyo-Ando, K., Inoue, T., Arai, H., 
and Mitani, S. (2010) Two very long chain fatty acid acyl-CoA synthetase genes, 
acs-20 and acs-22, have roles in the cuticle surface barrier in Caenorhabditis 
elegans. PloS one 5, e8857 
138. Ortiz de Montellano, P. R. (2008) Mechanism and role of covalent heme binding 
in the CYP4 family of P450 enzymes and the mammalian peroxidases. Drug 
Metab Rev 40, 405-426 
139. Meitzler, J. L., and Ortiz de Montellano, P. R. (2009) Caenorhabditis elegans and 
human dual oxidase 1 (DUOX1) "peroxidase" domains: insights into heme 
 123 
binding and catalytic activity. The Journal of biological chemistry 284, 18634-
18643 
140. Meitzler, J. L., and Ortiz de Montellano, P. R. (2011) Structural stability and heme 
binding potential of the truncated human dual oxidase 2 (DUOX2) peroxidase 
domain. Archives of biochemistry and biophysics 512, 197-203 
141. Zamocky, M., Jakopitsch, C., Furtmuller, P. G., Dunand, C., and Obinger, C. 
(2008) The peroxidase-cyclooxygenase superfamily: Reconstructed evolution of 
critical enzymes of the innate immune system. Proteins 72, 589-605 
142. Stampler, J., Bellei, M., Soudi, M., Gruber, C., Battistuzzi, G., Furtmuller, P. G., 
and Obinger, C. (2011) Manipulating the proximal triad His-Asn-Arg in human 
myeloperoxidase. Archives of biochemistry and biophysics 516, 21-28 
143. Hunt-Newbury, R., Viveiros, R., Johnsen, R., Mah, A., Anastas, D., Fang, L., 
Halfnight, E., Lee, D., Lin, J., Lorch, A., McKay, S., Okada, H. M., Pan, J., 
Schulz, A. K., Tu, D., Wong, K., Zhao, Z., Alexeyenko, A., Burglin, T., 
Sonnhammer, E., Schnabel, R., Jones, S. J., Marra, M. A., Baillie, D. L., and 
Moerman, D. G. (2007) High-throughput in vivo analysis of gene expression in 
Caenorhabditis elegans. PLoS Biol 5, e237 
144. McKay, S. J., Johnsen, R., Khattra, J., Asano, J., Baillie, D. L., Chan, S., Dube, 
N., Fang, L., Goszczynski, B., Ha, E., Halfnight, E., Hollebakken, R., Huang, P., 
Hung, K., Jensen, V., Jones, S. J., Kai, H., Li, D., Mah, A., Marra, M., McGhee, 
J., Newbury, R., Pouzyrev, A., Riddle, D. L., Sonnhammer, E., Tian, H., Tu, D., 
Tyson, J. R., Vatcher, G., Warner, A., Wong, K., Zhao, Z., and Moerman, D. G. 
(2003) Gene expression profiling of cells, tissues, and developmental stages of 
the nematode C. elegans. Cold Spring Harb Symp Quant Biol 68, 159-169 
145. Silhavy, T. J., Kahne, D., and Walker, S. (2010) The Bacterial Cell Envelope. 
Cold Spring Harb Perspect Biol 2 
146. Celniker, S. E., Dillon, L. A., Gerstein, M. B., Gunsalus, K. C., Henikoff, S., 
Karpen, G. H., Kellis, M., Lai, E. C., Lieb, J. D., MacAlpine, D. M., Micklem, G., 
Piano, F., Snyder, M., Stein, L., White, K. P., and Waterston, R. H. (2009) 
Unlocking the secrets of the genome. Nature 459, 927-930 
147. Simmer, F., Moorman, C., van der Linden, A. M., Kuijk, E., van den Berghe, P. 
V., Kamath, R. S., Fraser, A. G., Ahringer, J., and Plasterk, R. H. (2003) 
Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals 
novel gene functions. PLoS Biol 1, E12 
148. Dodd, W., Tang, L., Lone, J. C., Wimberly, K., Wu, C. W., Consalvo, C., Wright, 
J. E., Pujol, N., and Choe, K. P. (2018) A Damage Sensor Associated with the 
 124 
Cuticle Coordinates Three Core Environmental Stress Responses in 
Caenorhabditis elegans. Genetics 208, 1467-1482 
149. O'Rourke, D., Baban, D., Demidova, M., Mott, R., and Hodgkin, J. (2006) 
Genomic clusters, putative pathogen recognition molecules, and antimicrobial 
genes are induced by infection of C. elegans with M. nematophilum. Genome 
Res 16, 1005-1016 
150. Schulenburg, H., and Boehnisch, C. (2008) Diversification and adaptive 
sequence evolution of Caenorhabditis lysozymes (Nematoda: Rhabditidae). BMC 
Evol Biol 8, 114 
151. Kramer, J. M., Johnson, J. J., Edgar, R. S., Basch, C., and Roberts, S. (1988) 
The sqt-1 gene of C. elegans encodes a collagen critical for organismal 
morphogenesis. Cell 55, 555-565 
152. von Mende, N., Bird, D. M., Albert, P. S., and Riddle, D. L. (1988) dpy-13: a 
nematode collagen gene that affects body shape. Cell 55, 567-576 
153. Johnstone, I. L., Shafi, Y., and Barry, J. D. (1992) Molecular analysis of 
mutations in the Caenorhabditis elegans collagen gene dpy-7. The EMBO journal 
11, 3857-3863 
154. Kim, D. H., and Ewbank, J. J. (2018) Signaling in the innate immune response. 
WormBook : the online review of C. elegans biology 2018, 1-35 
155. Rouger, V., Bordet, G., Couillault, C., Monneret, S., Mailfert, S., Ewbank, J. J., 
Pujol, N., and Marguet, D. (2014) Independent synchronized control and 
visualization of interactions between living cells and organisms. Biophysical 
journal 106, 2096-2104 
156. Yook, K., and Hodgkin, J. (2007) Mos1 mutagenesis reveals a diversity of 
mechanisms affecting response of Caenorhabditis elegans to the bacterial 
pathogen Microbacterium nematophilum. Genetics 175, 681-697 
157. Partridge, F. A., Tearle, A. W., Gravato-Nobre, M. J., Schafer, W. R., and 
Hodgkin, J. (2008) The C. elegans glycosyltransferase BUS-8 has two distinct 
and essential roles in epidermal morphogenesis. Developmental biology 317, 
549-559 
158. Palaima, E., Leymarie, N., Stroud, D., Mizanur, R. M., Hodgkin, J., Gravato-
Nobre, M. J., Costello, C. E., and Cipollo, J. F. (2010) The Caenorhabditis 
elegans bus-2 mutant reveals a new class of O-glycans affecting bacterial 
resistance. The Journal of biological chemistry 285, 17662-17672 
 125 
159. Gravato-Nobre, M. J., Stroud, D., O'Rourke, D., Darby, C., and Hodgkin, J. 
(2011) Glycosylation genes expressed in seam cells determine complex surface 
properties and bacterial adhesion to the cuticle of Caenorhabditis elegans. 
Genetics 187, 141-155 
160. Cipollo, J. F., Awad, A. M., Costello, C. E., and Hirschberg, C. B. (2004) srf-3, a 
mutant of Caenorhabditis elegans, resistant to bacterial infection and to biofilm 
binding, is deficient in glycoconjugates. The Journal of biological chemistry 279, 
52893-52903 
161. Drace, K., McLaughlin, S., and Darby, C. (2009) Caenorhabditis elegans BAH-1 
is a DUF23 protein expressed in seam cells and required for microbial biofilm 
binding to the cuticle. PloS one 4, e6741 
162. Labrousse, A., Chauvet, S., Couillault, C., Kurz, C. L., and Ewbank, J. J. (2000) 
Caenorhabditis elegans is a model host for Salmonella typhimurium. Current 
Biology 10, 1543-1545 
163. Stampler, J., Bellei, M., Soudi, M., Gruber, C., Battistuzzi, G., Furtmüller, P. G., 
and Obinger, C. (2011) Manipulating the proximal triad His–Asn–Arg in human 
myeloperoxidase. Archives of biochemistry and biophysics 516, 21-28 
164. Zhang, Y., Li, W., Li, L., Li, Y., Fu, R., Zhu, Y., Li, J., Zhou, Y., Xiong, S., and 
Zhang, H. (2015) Structural damage in the C. elegans epidermis causes release 
of STA-2 and induction of an innate immune response. Immunity 42, 309-320 
165. Hiatt, S. M., Shyu, Y. J., Duren, H. M., and Hu, C. D. (2008) Bimolecular 
fluorescence complementation (BiFC) analysis of protein interactions in 
Caenorhabditis elegans. Methods 45, 185-191 
166. Meitzler, J. L., Hinde, S., Banfi, B., Nauseef, W. M., and Ortiz de Montellano, P. 
R. (2013) Conserved cysteine residues provide a protein-protein interaction 
surface in dual oxidase (DUOX) proteins. The Journal of biological chemistry 
288, 7147-7157 
 
 
Vita 
Yi Liu was born in Changsha, Hunan, China, the daughter of Tiehui Liu and Junqiang 
Chen. After graduated from the High School Attached to Hunan Normal University, Yi was 
 126 
admitted to the Honors Program of Biological Science at Huazhong Agricultural University in 
Wuhan, China. She worked as an undergraduate researcher at the National Key Laboratory of 
Microbiology during her junior and senior years and received the degree of Bachelor of Science 
in June 2008. She then went to Auburn University, Alabama and obtained her Master of Science 
in 2011. After that, she joined UTHealth at Houston first as a research scientist then as a 
graduate student in the Microbiology and Molecular Genetics program and joined Dr. Danielle 
Garsin’s laboratory in August 2015.  
 
Permanent address: 
3225 Seneca Landing Ln 
Pearland, Texas, 77584 
